Tekla World Healthcare Fund (THW) N-PX Annual report of proxy voting record

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
	OMB Number:  3235-0582
	Expires:  May 31, 2021
	Estimated average burden
	hours per response........7.2

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number  811- 06565

Tekla World Healthcare Fund

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla World Healthcare Fund

100 Federal Street, 19th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code:  617-772-8500

Date of fiscal year end:  September 30

Date of reporting period:  7/1/18-6/30/19

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

Item 1. Proxy Voting Record.

THW Vote Summary

ABBOTT LABORATORIES

Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	26-Apr-2019
Record Date	27-Feb-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	R.J. Alpern		For	For
	2	R.S. Austin		For	For
	3	S.E. Blount		For	For
	4	M.A. Kumbier		For	For
	5	E.M. Liddy		For	For
	6	N. McKinstry		For	For
	7	P.N. Novakovic		For	For
	8	W.A. Osborn		For	For
	9	S.C. Scott III		For	For
	10	D.J. Starks		For	For
	11	J.G. Stratton		For	For
	12	G.F. Tilton		For	For
	13	M.D. White		For	For
2.	Ratification of Ernst & Young LLP as Auditors		Management	For	For
3.	Say on Pay - An Advisory Vote to Approve Executive Compensation		Management	For	For
4.	Shareholder Proposal - Independent Board Chairman		Shareholder	For	Against

ABBVIE INC.

Security	00287Y109	Meeting Type	Annual
Ticker Symbol	ABBV	Meeting Date	03-May-2019
Record Date	08-Mar-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	William H.L. Burnside		For	For
	2	Brett J. Hart		For	For
	3	Edward J. Rapp		For	For
2.	Ratification of Ernst & Young LLP as AbbVie’s independent registered public accounting firm for 2019		Management	For	For
3.	Say on Pay - An advisory vote on the approval of executive compensation		Management	For	For
4.	Approval of a management proposal regarding amendment of the certificate of incorporation for a simple majority vote		Management	For	For
5.	Stockholder Proposal - to Issue an Annual Report on Lobbying		Shareholder	Against	For
6.	Stockholder Proposal - to Issue a Compensation Committee Report on Drug Pricing		Shareholder	Against	For
7.	Stockholder Proposal - to Adopt a Policy to Require Independent Chairman		Shareholder	For	Against

ACADIA HEALTHCARE COMPANY, INC.

Security	00404A109	Meeting Type	Annual
Ticker Symbol	ACHC	Meeting Date	02-May-2019
Record Date	11-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: William F. Grieco	Management	For	For
1.2	Election of Director: Reeve B. Waud	Management	For	For
2.	Advisory vote on the compensation of the Company’s named executive officers as presented in the Proxy Statement.	Management	For	For
3.	Advisory vote on the frequency of the advisory vote on the compensation of the Company’s named executive officers.	Management	1 Year	For
4.	Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For

ADAPTIMMUNE THERAPEUTICS PLC

Security	00653A107	Meeting Type	Annual
Ticker Symbol	ADAP	Meeting Date	02-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To re-elect as a director, John Furey, who retires in accordance with the Articles of Association.	Management	For	For
O2	To re-elect as a director, Ali Behbahani, who retires by rotation in accordance with the Articles of Association.	Management	For	For
O3	To re-elect as a director, James Noble, who retires by rotation in accordance with the Articles of Association.	Management	For	For
O4	To re-appoint KPMG LLP as auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.	Management	For	For
O5	To authorize the Audit Committee to determine our auditors’ remuneration for the fiscal year ending December 31, 2019.	Management	For	For
O6	To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2018 and to note that the Directors do not recommend the payment of any dividend for the year ended December 31, 2018.	Management	For	For
O7	To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2018.	Management	For	For
O8	To indicate, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of the Company’s named executive officers.	Management	1 Year	For
O9	To receive and approve our U.K. statutory directors’ remuneration report for the year ended December 31, 2018.	Management	For	For
O10	To authorize the Directors under Section 551 of the U.K. Companies Act 2006 (the “2006 Act”) to allot shares or to grant rights to subscribe for or to convert any security into shares.	Management	For	For
S11	To empower the Directors to allot equity securities for cash pursuant to Section 570(1) of the 2006 Act as if Section 561(1) of the 2006 Act did not apply to that allotment.	Management	For	For

ALEXION PHARMACEUTICALS, INC.

Security	015351109	Meeting Type	Annual
Ticker Symbol	ALXN	Meeting Date	14-May-2019
Record Date	15-Mar-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Felix J. Baker		For	For
	2	David R. Brennan		For	For
	3	Christopher J. Coughlin		For	For
	4	Deborah Dunsire		For	For
	5	Paul A. Friedman		For	For
	6	Ludwig N. Hantson		For	For
	7	John T. Mollen		For	For
	8	Francois Nader		For	For
	9	Judith A. Reinsdorf		For	For
	10	Andreas Rummelt		For	For
2.	Ratification of appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.		Management	For	For
3.	Approval of a non-binding advisory vote of the 2018 compensation paid to Alexion’s named executive officers.		Management	For	For
4.	Shareholder proposal requesting certain proxy access Bylaw amendments.		Shareholder	Against	For

ALIGN TECHNOLOGY, INC.

Security	016255101	Meeting Type	Annual
Ticker Symbol	ALGN	Meeting Date	15-May-2019
Record Date	20-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kevin J. Dallas	Management	For	For
1b.	Election of Director: Joseph M. Hogan	Management	For	For
1c.	Election of Director: Joseph Lacob	Management	For	For
1d.	Election of Director: C. Raymond Larkin, Jr.	Management	For	For
1e.	Election of Director: George J. Morrow	Management	For	For
1f.	Election of Director: Thomas M. Prescott	Management	For	For
1g.	Election of Director: Andrea L. Saia	Management	For	For
1h.	Election of Director: Greg J. Santora	Management	For	For
1i.	Election of Director: Susan E. Siegel	Management	For	For
1j.	Election of Director: Warren S. Thaler	Management	For	For
2.	Ratification Of Appointment Of Independent Registered Public Accountant: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.’s independent registered public accountants for the fiscal year ending December 31, 2019.	Management	For	For
3.	Advisory Vote To Approve Named Executive Officer Compensation.	Management	For	For

ALLERGAN PLC

Security	G0177J108	Meeting Type	Annual
Ticker Symbol	AGN	Meeting Date	01-May-2019
Record Date	05-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Nesli Basgoz, M.D.	Management	For	For
1b.	Election of Director: Joseph H. Boccuzi	Management	For	For
1c.	Election of Director: Christopher W. Bodine	Management	For	For
1d.	Election of Director: Adriane M. Brown	Management	For	For
1e.	Election of Director: Christopher J. Coughlin	Management	For	For
1f.	Election of Director: Carol Anthony (John) Davidson	Management	For	For
1g.	Election of Director: Thomas C. Freyman	Management	For	For
1h.	Election of Director: Michael E. Greenberg, PhD	Management	For	For
1i.	Election of Director: Robert J. Hugin	Management	For	For
1j.	Election of Director: Peter J. McDonnell, M.D.	Management	For	For
1k.	Election of Director: Brenton L. Saunders	Management	For	For
2.	To approve, in a non-binding vote, Named Executive Officer compensation.	Management	For	For
3.	To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for the fiscal year ending December 31, 2019 and to authorize, in a binding vote, the Board of Directors, acting through its Audit and Compliance Committee, to determine PricewaterhouseCoopers LLP’s remuneration.	Management	For	For
4.	To renew the authority of the directors of the Company (the “Directors”) to issue shares.	Management	For	For
5a.	To renew the authority of the Directors to issue shares for cash without first offering shares to existing shareholders.	Management	For	For
5b.	To authorize the Directors to allot new shares up to an additional 5% for cash in connection with an acquisition or other capital investment.	Management	For	For
6.	To consider a shareholder proposal requiring an independent Board Chairman (immediate change), if properly presented at the meeting.	Shareholder	For	Against

AMARIN CORPORATION PLC

Security	023111206	Meeting Type	Annual
Ticker Symbol	AMRN	Meeting Date	20-May-2019
Record Date	11-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To re-elect Mr. Jan van Heek as a director.	Management	For	For
2.	To re-elect Ms. Kristine Peterson as a director.	Management	For	For
3.	To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 25 to 55 of the accompanying Proxy Statement.	Management	For	For
4.	To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 9 to 10 of the accompanying Proxy Statement.	Management	For	For
5.	To generally and unconditionally reauthorize the Board of Directors of the Company to exercise all powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of GBP 148,000,000 (being the aggregate nominal amount of GBP 125,000,000 in respect of ordinary shares and GBP 23,000,000 in respect of preference shares) as described in full on pages 11 to 12 of the accompanying Proxy Statement.	Management	For	For
6.	To, subject to the passing of Resolution No. 5, disapply statutory pre-emption rights otherwise applicable to shares in the Company allotted by the Board of Directors, up to an aggregate nominal amount of GBP 148,000,000 (being the aggregate nominal amount of GBP 125,000,000 in respect of ordinary shares and GBP 23,000,000 in respect of preference shares) as described in full on pages 13 to 14 of the accompanying Proxy Statement.	Management	For	For

AMERISOURCEBERGEN CORPORATION

Security	03073E105	Meeting Type	Annual
Ticker Symbol	ABC	Meeting Date	28-Feb-2019
Record Date	31-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Ornella Barra	Management	For	For
1.2	Election of Director: Steven H. Collis	Management	For	For
1.3	Election of Director: D. Mark Durcan	Management	For	For
1.4	Election of Director: Richard W. Gochnauer	Management	For	For
1.5	Election of Director: Lon R. Greenberg	Management	For	For
1.6	Election of Director: Jane E. Henney, M.D.	Management	For	For
1.7	Election of Director: Kathleen W. Hyle	Management	For	For
1.8	Election of Director: Michael J. Long	Management	For	For
1.9	Election of Director: Henry W. McGee	Management	For	For
2.	Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2019.	Management	For	For
3.	Advisory vote to approve the compensation of named executive officers.	Management	For	For
4.	Stockholder proposal, if properly presented, to permit stockholders to act by written consent.	Shareholder	Against	For
5.	Stockholder proposal, if properly presented, to urge the Board to adopt a policy that no financial performance metric be adjusted to exclude legal or compliance costs in determining executive compensation.	Shareholder	Against	For

AMGEN INC.

Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	21-May-2019
Record Date	22-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Dr. Wanda M. Austin	Management	For	For
1b.	Election of Director: Mr. Robert A. Bradway	Management	For	For
1c.	Election of Director: Dr. Brian J. Druker	Management	For	For
1d.	Election of Director: Mr. Robert A. Eckert	Management	For	For
1e.	Election of Director: Mr. Greg C. Garland	Management	For	For
1f.	Election of Director: Mr. Fred Hassan	Management	For	For
1g.	Election of Director: Dr. Rebecca M. Henderson	Management	For	For
1h.	Election of Director: Mr. Charles M. Holley, Jr.	Management	For	For
1i.	Election of Director: Dr. Tyler Jacks	Management	For	For
1j.	Election of Director: Ms. Ellen J. Kullman	Management	For	For
1k.	Election of Director: Dr. Ronald D. Sugar	Management	For	For
1l.	Election of Director: Dr. R. Sanders Williams	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2019.	Management	For	For

ANTHEM, INC.

Security	036752103	Meeting Type	Annual
Ticker Symbol	ANTM	Meeting Date	15-May-2019
Record Date	08-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director Nominee: Bahija Jallal	Management	For	For
1.2	Election of Director Nominee: Elizabeth E. Tallett	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2019.	Management	For	For
3.	Advisory vote to approve the compensation of our named executive officers.	Management	For	For
4.	To approve proposed amendments to our Articles of Incorporation to eliminate the classified board structure when permitted under our contractual obligations with the Blue Cross and Blue Shield Association.	Management	For	For
5.	Shareholder proposal to elect each director annually.	Shareholder	For

ARDELYX, INC

Security	039697107	Meeting Type	Annual
Ticker Symbol	ARDX	Meeting Date	13-Jun-2019
Record Date	18-Apr-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Geoffrey A. Block, M.D.		For	For
	2	David Mott		For	For
	3	Michael Raab		For	For
2.	To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young, LLP as the independent registered public accounting firm of the Company for the fiscal year ended December 31, 2019.		Management	For	For

ASTELLAS PHARMA INC.

Security	J03393105	Meeting Type	Annual General Meeting
Ticker Symbol	ALPMF	Meeting Date	18-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2	Amend Articles to: Allow the Board of Directors to Authorize Appropriation of Surplus and Purchase Own Shares	Management	For	For
3.1	Appoint a Director who is not Audit and Supervisory Committee Member Hatanaka, Yoshihiko	Management	For	For
3.2	Appoint a Director who is not Audit and Supervisory Committee Member Yasukawa, Kenji	Management	For	For
3.3	Appoint a Director who is not Audit and Supervisory Committee Member Okamura, Naoki	Management	For	For
3.4	Appoint a Director who is not Audit and Supervisory Committee Member Sekiyama, Mamoru	Management	For	For
3.5	Appoint a Director who is not Audit and Supervisory Committee Member Yamagami, Keiko	Management	For	For
3.6	Appoint a Director who is not Audit and Supervisory Committee Member Kawabe, Hiroshi	Management	For	For
3.7	Appoint a Director who is not Audit and Supervisory Committee Member Ishizuka, Tatsuro	Management	For	For
4	Appoint a Director who is Audit and Supervisory Committee Member Shibumura, Haruko	Management	For	For
5	Appoint a Substitute Director who is Audit and Supervisory Committee Member Takahashi, Raita	Management	For	For
6	Approve Details of the Compensation to be received by Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For
7	Approve Details of the Stock Compensation to be received by Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For
8	Approve Payment of Bonuses to Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For

ASTRAZENECA PLC

Security	046353108	Meeting Type	Annual
Ticker Symbol	AZN	Meeting Date	26-Apr-2019
Record Date	05-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2018	Management	For	For
2.	To confirm dividends	Management	For	For
3.	To reappoint PricewaterhouseCoopers LLP as Auditor	Management	For	For
4.	To authorise the Directors to agree the remuneration of the Auditor	Management	For	For
5a.	To elect or re-elect of the Director: Leif Johansson	Management	For	For
5b.	To elect or re-elect of the Director: Pascal Soriot	Management	For	For
5c.	To elect or re-elect of the Director: Marc Dunoyer	Management	For	For
5d.	To elect or re-elect of the Director: Geneviève Berger	Management	For	For
5e.	To elect or re-elect of the Director: Philip Broadley	Management	For	For
5f.	To elect or re-elect of the Director: Graham Chipchase	Management	For	For
5g.	To elect or re-elect of the Director: Deborah DiSanzo	Management	For	For
5h.	To elect or re-elect of the Director: Sheri McCoy	Management	For	For
5i.	To elect or re-elect of the Director: Tony Mok	Management	For	For
5j.	To elect or re-elect of the Director: Nazneen Rahman	Management	For	For
5k.	To elect or re-elect of the Director: Marcus Wallenberg	Management	For	For
6.	To approve the Annual Report on Remuneration for the year ended 31 December 2018	Management	For	For
7.	To authorise limited political donations	Management	For	For
8.	To authorise the Directors to allot shares	Management	For	For
9.	To authorise the Directors to disapply pre-emption rights	Management	For	For
10.	To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments	Management	For	For
11.	To authorise the Company to purchase its own shares	Management	For	For
12.	To reduce the notice period for general meetings	Management	For	For

BAUSCH HEALTH COMPANIES

Security	071734107	Meeting Type	Annual
Ticker Symbol	BHC	Meeting Date	30-Apr-2019
Record Date	04-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Richard U. De Schutter	Management	For	For
1b.	Election of Director: D. Robert Hale	Management	For	For
1c.	Election of Director: Dr. Argeris (Jerry) N. Karabelas	Management	For	For
1d.	Election of Director: Sarah B. Kavanagh	Management	For	For
1e.	Election of Director: Joseph C. Papa	Management	For	For
1f.	Election of Director: John A. Paulson	Management	For	For
1g.	Election of Director: Robert N. Power	Management	For	For
1h.	Election of Director: Russel C. Robertson	Management	For	For
1i.	Election of Director: Thomas W. Ross, Sr.	Management	For	For
1j.	Election of Director: Andrew C. von Eschenbach, M.D.	Management	For	For
1k.	Election of Director: Amy B. Wechsler, M.D.	Management	For	For
2.	The approval, in an advisory vote, of the compensation of our Named Executive Officers.	Management	For	For
3.	To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2020 Annual Meeting of Shareholders and to authorize the Company’s Board of Directors to fix the auditors’ remuneration.	Management	For	For

BAXTER INTERNATIONAL INC.

Security	071813109	Meeting Type	Annual
Ticker Symbol	BAX	Meeting Date	07-May-2019
Record Date	14-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: José (Joe) E. Almeida	Management	For	For
1b.	Election of Director: Thomas F. Chen	Management	For	For
1c.	Election of Director: John D. Forsyth	Management	For	For
1d.	Election of Director: James R. Gavin III	Management	For	For
1e.	Election of Director: Peter S. Hellman	Management	For	For
1f.	Election of Director: Michael F. Mahoney	Management	For	For
1g.	Election of Director: Patricia B. Morrison	Management	For	For
1h.	Election of Director: Stephen N. Oesterle	Management	For	For
1i.	Election of Director: Cathy R. Smith	Management	For	For
1j.	Election of Director: Thomas T. Stallkamp	Management	For	For
1k.	Election of Director: Albert P.L. Stroucken	Management	For	For
1l.	Election of Director: Amy A. Wendell	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Ratification of Appointment of Independent Registered Public Accounting Firm	Management	For	For
4.	Stockholder Proposal - Independent Board Chairman	Shareholder	For	Against
5.	Stockholder Proposal- Right to Act by Written Consent	Shareholder	Against	For

BAYER AG

Security	D0712D163	Meeting Type	Annual General Meeting
Ticker Symbol	BAYRY	Meeting Date	26-Apr-2019
Record Date	19-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1	Distribution Of The Profit: Dividends Of EUR2.80 Per Share	Management	For	For
2	Ratification Of The Actions Of The Board Of Management	Management	For	For
3	Ratification Of The Actions Of The Supervisory Board	Management	For	For
4	Supervisory Board Election: Simone Bagel-Trah	Management	For	For
5.A	Authorization To Acquire And Use Own Shares	Management	For	For
5.B	Authorization To Acquire Own Shares Using Derivatives	Management	For	For
6	Election Of The Auditor (Full-Year, Half- Year And Q3 2019: Q1 2020): Deloitte GMBH	Management	For	For

BECTON, DICKINSON AND COMPANY

Security	075887109	Meeting Type	Annual
Ticker Symbol	BDX	Meeting Date	22-Jan-2019
Record Date	07-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Catherine M. Burzik	Management	For	For
1b.	Election of Director: R. Andrew Eckert	Management	For	For
1c.	Election of Director: Vincent A. Forlenza	Management	For	For
1d.	Election of Director: Claire M. Fraser	Management	For	For
1e.	Election of Director: Jeffrey W. Henderson	Management	For	For
1f.	Election of Director: Christopher Jones	Management	For	For
1g.	Election of Director: Marshall O. Larsen	Management	For	For
1h.	Election of Director: David F. Melcher	Management	For	For
1i.	Election of Director: Claire Pomeroy	Management	For	For
1j.	Election of Director: Rebecca W. Rimel	Management	For	For
1k.	Election of Director: Timothy M. Ring	Management	For	For
1l.	Election of Director: Bertram L. Scott	Management	For	For
2.	Ratification of selection of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Amendment to BD’s Restated Certificate of Incorporation.	Management	For	For

BEIGENE LTD

Security	07725L102	Meeting Type	Special
Ticker Symbol	BGNE	Meeting Date	07-Dec-2018
Record Date	25-Oct-2018

Item	Proposal	Proposed by	Vote	For/Against Management
S1	THAT the adoption of the official Chinese company name for BeiGene, Ltd. be and is hereby approved and adopted. Please see enclosed Company materials for full proposal.	Management	For	For
S2	THAT the Fifth Amended and Restated Memorandum and Articles of Association of the Company be and are hereby approved and adopted.	Management	For	For
O3	THAT the granting of a share issue mandate to the Board of Directors of the Company to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares not exceeding 20% of the total number of issued ordinary shares of the Company as at the date of passing of this ordinary resolution ...(see enclosed Company materials for full proposal).	Management	For	For
O4	THAT the Company and its underwriters be and are hereby authorized, at their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the “Existing Shareholders”), up to a maximum amount of shares in order to ...(see enclosed Company materials for full proposal).	Management	For	For
O5	THAT the BeiGene, Ltd. Second Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved and adopted.	Management	For	For
O6	THAT the BeiGene, Ltd. Second Amended and Restated 2018 Employee Share Purchase Plan be and is hereby approved and adopted.	Management	For	For

BEIGENE LTD

Security	07725L102	Meeting Type	Annual
Ticker Symbol	BGNE	Meeting Date	05-Jun-2019
Record Date	18-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	THAT Ranjeev Krishana be and is hereby re-elected to serve as a Class III director of the Company until the 2022 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
2.	THAT Xiaodong Wang be and is hereby re-elected to serve as a Class III director of the Company until the 2022 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
3.	THAT Qingqing Yi be and is hereby re-elected to serve as a Class III director of the Company until the 2022 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
4.	THAT Jing-Shyh (Sam) Su be and is hereby re-elected to serve as a Class I director of the Company until the 2020 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
5.	THAT the appointment of Ernst & Young Hua Ming LLP and Ernst & Young as the Company’s independent registered public accounting firms for the year ending December 31, 2019 be and is hereby approved, ratified and confirmed.	Management	For	For
6.	THAT the granting of a share issue mandate to the Board of Directors of the Company to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares not exceeding 20% of the total number of issued ordinary shares of the Company as at the date of passing of this ordinary resolution up to the next annual general meeting of the Company be and is hereby approved.	Management	For	For
7.	THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the “Existing Shareholders”), up to a maximum amount of shares in order to maintain the same shareholding percentage of each of the Existing Shareholders (based on the then-outstanding share ...(due to space limits, see proxy material for full proposal).	Management	For	For
8.	THAT, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.	Management	For	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	4-Sep-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Director Election	Management	For	For
2	General Authorizing Resolution	Management	For	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	4-Sep-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Director Removal	Management	For	For
2	General Authorizing Resolution	Management	For	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	1-Nov-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment of Certificate of Incorporation	Management	For	For
2	Amendment and Restatement of 2013 Stock Option and Grant Plan	Management	For	For
3	General Authorizing Resolution	Management	For	For

BIOGEN INC.

Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	19-Jun-2019
Record Date	22-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: John R. Chiminski	Management	For	For
1b.	Election of Director: Alexander J. Denner	Management	For	For
1c.	Election of Director: Caroline D. Dorsa	Management	For	For
1d.	Election of Director: William A. Hawkins	Management	For	For
1e.	Election of Director: Nancy L. Leaming	Management	For	For
1f.	Election of Director: Jesus B. Mantas	Management	For	For
1g.	Election of Director: Richard C. Mulligan	Management	For	For
1h.	Election of Director: Robert W. Pangia	Management	For	For
1i.	Election of Director: Stelios Papadopoulos	Management	For	For
1j.	Election of Director: Brian S. Posner	Management	For	For
1k.	Election of Director: Eric K. Rowinsky	Management	For	For
1l.	Election of Director: Lynn Schenk	Management	For	For
1m.	Election of Director: Stephen A. Sherwin	Management	For	For
1n.	Election of Director: Michel Vounatsos	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
3.	Say on Pay - To approve an advisory vote on executive compensation.	Management	For	For

BOSTON SCIENTIFIC CORPORATION

Security	101137107	Meeting Type	Annual
Ticker Symbol	BSX	Meeting Date	09-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Nelda J. Connors	Management	For	For
1b.	Election of Director: Charles J. Dockendorff	Management	For	For
1c.	Election of Director: Yoshiaki Fujimori	Management	For	For
1d.	Election of Director: Donna A. James	Management	For	For
1e.	Election of Director: Edward J. Ludwig	Management	For	For
1f.	Election of Director: Stephen P. MacMillan	Management	For	For
1g.	Election of Director: Michael F. Mahoney	Management	For	For
1h.	Election of Director: David J. Roux	Management	For	For
1i.	Election of Director: John E. Sununu	Management	For	For
1j.	Election of Director: Ellen M. Zane	Management	For	For
2.	To approve, on a non-binding, advisory basis, named executive officer compensation.	Management	For	For
3.	To approve an amendment and restatement of our By- Laws to provide for a majority vote standard in uncontested director elections.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2019 fiscal year.	Management	For	For

BRISTOL-MYERS SQUIBB COMPANY

Security	110122108	Meeting Type	Contested-Special
Ticker Symbol	BMY	Meeting Date	12-Apr-2019
Record Date	01-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Stock Issuance Proposal: To approve the issuance of shares of Bristol-Myers Squibb Company common stock to stockholders of Celgene Corporation in the merger between Celgene Corporation and Burgundy Merger Sub, Inc., a wholly-owned subsidiary of Bristol-Myers Squibb Company, pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of January 2, 2019, as it may be amended from time to time, among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc. and Celgene Corporation.	Management	For	For
2.	Adjournment Proposal: To approve the adjournment from time to time of the special meeting of the stockholders of Bristol- Myers Squibb Company if necessary to solicit additional proxies if there are not sufficient votes at the time of the special meeting, or any adjournment or postponement thereof, to approve the Stock Issuance Proposal.	Management	For	For

BRISTOL-MYERS SQUIBB COMPANY

Security	110122108	Meeting Type	Annual
Ticker Symbol	BMY	Meeting Date	29-May-2019
Record Date	30-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter J. Arduini	Management	For	For
1B.	Election of Director: Robert Bertolini	Management	For	For
1C.	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1D.	Election of Director: Matthew W. Emmens	Management	For	For
1E.	Election of Director: Michael Grobstein	Management	For	For
1F.	Election of Director: Alan J. Lacy	Management	For	For
1G.	Election of Director: Dinesh C. Paliwal	Management	For	For
1H.	Election of Director: Theodore R. Samuels	Management	For	For
1I.	Election of Director: Vicki L. Sato, Ph.D.	Management	For	For
1J.	Election of Director: Gerald L. Storch	Management	For	For
1K.	Election of Director: Karen H. Vousden, Ph.D.	Management	For	For
2.	Advisory vote to approve the compensation of our Named Executive Officers	Management	For	For
3.	Ratification of the appointment of an independent registered public accounting firm	Management	For	For
4.	Shareholder Proposal on Right to Act by Written Consent	Shareholder	Against	For

CARDINAL HEALTH, INC.

Security	14149Y108	Meeting Type	Annual
Ticker Symbol	CAH	Meeting Date	07-Nov-2018
Record Date	10-Sep-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of director: Colleen F. Arnold	Management	For	For
1b.	Election of director: Carrie S. Cox	Management	For	For
1c.	Election of director: Calvin Darden	Management	For	For
1d.	Election of director: Bruce L. Downey	Management	For	For
1e.	Election of director: Patricia A. Hemingway Hall	Management	For	For
1f.	Election of director: Akhil Johri	Management	For	For
1g.	Election of director: Michael C. Kaufmann	Management	For	For
1h.	Election of director: Gregory B. Kenny	Management	For	For
1i.	Election of director: Nancy Killefer	Management	For	For
2.	Proposal to ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2019.	Management	For	For
3.	Proposal to approve, on a non-binding advisory basis, the compensation of our named executive officers.	Management	For	For
4.	Shareholder proposal, if properly presented, on a policy to not exclude legal and compliance costs for purposes of determining executive compensation.	Shareholder	Against	For
5.	Shareholder proposal, if properly presented, on the ownership threshold for calling a special meeting of shareholders.	Shareholder	Against	For

CELGENE CORPORATION

Security	151020104	Meeting Type	Special
Ticker Symbol	CELG	Meeting Date	12-Apr-2019
Record Date	01-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adoption of the Agreement and Plan of Merger, dated as of January 2, 2019, as it may be amended from time to time (the merger agreement), among Bristol-Myers Squibb Company, a Delaware corporation (Bristol-Myers Squibb), Burgundy Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Bristol-Myers Squibb, and Celgene Corporation (Celgene), pursuant to which Burgundy Merger Sub, Inc. will be merged with and into Celgene (the merger).	Management	For	For
2.	Approval of the adjournment from time to time of the special meeting of the stockholders of Celgene (the Celgene special meeting) if necessary to solicit additional proxies if there are not sufficient votes to adopt the merger agreement at the time of the Celgene special meeting or any adjournment or postponement thereof.	Management	For	For
3.	Approval, on an advisory (non-binding) basis, of the compensation that will or may be paid or provided by Celgene to its named executive officers in connection with the merger.	Management	For	For

CELLDEX THERAPEUTICS, INC.

Security	15117B202	Meeting Type	Annual
Ticker Symbol	CLDX	Meeting Date	19-Jun-2019
Record Date	22-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	DIRECTOR	Management
	1      Anthony S. Marucci		For	For
	2      Keith L. Brownlie		For	For
	3      Herbert J. Conrad		For	For
	4      James J. Marino		For	For
	5      Harry H. Penner, Jr.		For	For
	6      Karen L. Shoos		For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For
3.	To approve an amendment to our 2008 Stock Option and Incentive Plan including an increase in the number of the shares reserved for issuance thereunder by 900,000 shares to 2,233,333 shares and certain other administrative changes.	Management	For	For
4.	To approve an amendment to our 2004 Employee Stock Purchase Plan to increase the shares reserved for issuance thereunder by 250,000 shares to 276,666 shares.	Management	For	For
5.	To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the proxy statement.	Management	For	For

CELLECTIS S.A.

Security	15117K103	Meeting Type	Annual
Ticker Symbol	CLLS	Meeting Date	25-Jun-2019
Record Date	10-Jun-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O1	Approval of the financial statements for the financial year ended December 31, 2018	Management	For	For
O2	Approval of the consolidated financial statements for the financial year ended December 31, 2018	Management	For	For
O3	Allocation of income for the financial year ended December 31, 2018	Management	For	For
O4	Approval of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code	Management	For	For
O5	Approval of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code	Management	For	For
O6	Approval of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code	Management	For	For
O7	Approval of 2018 Stock Option Plan and payment for the stock (Due to space limits, see proxy material for full proposal)	Management	For	For
O8	Authorization to be given to the board of directors to buy back Company shares	Management	For	For
E9	Authorization to be given to the board of directors for the (Due to space limits, see proxy material for full proposal)	Management	For	For
E10	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E11	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E12	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E13	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E14	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E15	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E16	Delegation granted to the board of directors to increase the (Due to space limits, see proxy material for full proposal)	Management	For	For
E17	Overall limitations to the amount of issuances made under the (Due to space limits, see proxy material for full proposal)	Management	For	For
E18	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E19	Authorization to be given to the board of directors to grant options to subscribe or purchase Company’s shares	Management	For	For
E20	Authorization be given to the board of directors for the (Due to space limits, see proxy material for full proposal)	Management	For	For
E21	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E22	Delegation of authority to be granted to the board of directors (Due to space limits, see proxy material for full proposal)	Management	For	For
E23	Authorization for the board of directors to freely allocate (Due to space limits, see proxy material for full proposal)	Management	For	For
E24	Overall limitations to the amount of issues made under the 19th (Due to space limits, see proxy material for full proposal)	Management	For	For
E25	Delegation to be granted to the board of directors for the (Due to space limits, see proxy material for full proposal)	Management	For

CENTENE CORPORATION

Security	15135B101	Meeting Type	Special
Ticker Symbol	CNC	Meeting Date	28-Jan-2019
Record Date	24-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock.	Management	For	For

CENTENE CORPORATION

Security	15135B101	Meeting Type	Annual
Ticker Symbol	CNC	Meeting Date	23-Apr-2019
Record Date	22-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Orlando Ayala	Management	For	For
1B.	Election of Director: John R. Roberts	Management	For	For
1C.	Election of Director: Tommy G. Thompson	Management	For	For
2.	Advisory Resolution To Approve Executive Compensation.	Management	For	For
3.	Ratification Of Appointment Of KPMG LLP As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2019.	Management	For	For
4.	The Stockholder Proposal Requesting Political Spending Disclosures As Described In The Proxy Statement.	Shareholder	Against	For

CENTENE CORPORATION

Security	15135B101	Meeting Type	Special
Ticker Symbol	CNC	Meeting Date	24-Jun-2019
Record Date	08-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To approve the issuance of Centene Corporation (“Centene”) common stock, par value $0.001 per share, pursuant to the Agreement and Plan of Merger, dated as of March 26, 2019, by and among Centene, Wellington Merger Sub I, Inc., Wellington Merger Sub II, Inc. and WellCare Health Plans, Inc., as may be amended from time to time (the “Share Issuance Proposal”).	Management	For	For
2.	To approve any proposal to adjourn the Special Meeting of Stockholders of Centene (the “Centene Special Meeting”) from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Centene Special Meeting to approve the Share Issuance Proposal.	Management	For	For

CHUGAI PHARMACEUTICAL CO.,LTD.

Security	J06930101	Meeting Type	Annual General Meeting
Ticker Symbol	CHGCF	Meeting Date	28-Mar-2019
Record Date	31-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Oku, Masayuki	Management	For	For
2.2	Appoint a Director Ichimaru, Yoichiro	Management	For	For
2.3	Appoint a Director Christoph Franz	Management	For	For
2.4	Appoint a Director William N. Anderson	Management	For	For
2.5	Appoint a Director James H. Sabry	Management	For	For
3.1	Appoint a Corporate Auditor Sato, Atsushi	Management	For	For
3.2	Appoint a Corporate Auditor Maeda, Yuko	Management	For	For

CIGNA CORPORATION

Security	125523100	Meeting Type	Annual
Ticker Symbol	CI	Meeting Date	24-Apr-2019
Record Date	25-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: David M. Cordani	Management	For	For
1b.	Election of Director: William J. DeLaney	Management	For	For
1c.	Election of Director: Eric J. Foss	Management	For	For
1d.	Election of Director: Elder Granger, MD, MG, USA	Management	For	For
1e.	Election of Director: Isaiah Harris, Jr.	Management	For	For
1f.	Election of Director: Roman Martinez IV	Management	For	For
1g.	Election of Director: Kathleen M. Mazzarella	Management	For	For
1h.	Election of Director: Mark B. McClellan, MD, PhD	Management	For	For
1i.	Election of Director: John M. Partridge	Management	For	For
1j.	Election of Director: William L. Roper, MD, MPH	Management	For	For
1k.	Election of Director: Eric C. Wiseman	Management	For	For
1l.	Election of Director: Donna F. Zarcone	Management	For	For
1m.	Election of Director: William D. Zollars	Management	For	For
2.	Advisory approval of Cigna’s executive compensation.	Management	For	For
3.	Ratification of appointment of PricewaterhouseCoopers LLP as Cigna’s independent registered public accounting firm for 2019.	Management	For	For
4.	Shareholder proposal - Increase shareholder rights to include action by written consent.	Shareholder	Against	For
5.	Shareholder proposal - Cyber risk report	Shareholder	Against	For
6.	Shareholder proposal - Gender pay gap report	Shareholder	Against	For

COMMUNITY HEALTH SYSTEMS, INC.

Security	203668108	Meeting Type	Annual
Ticker Symbol	CYH	Meeting Date	14-May-2019
Record Date	18-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: John A. Clerico	Management	For	For
1b.	Election of Director: Michael Dinkins	Management	For	For
1c.	Election of Director: James S. Ely II	Management	For	For
1d.	Election of Director: John A. Fry	Management	For	For
1e.	Election of Director: Tim L. Hingtgen	Management	For	For
1f.	Election of Director: Elizabeth T. Hirsch	Management	For	For
1g.	Election of Director: William Norris Jennings, M.D.	Management	For	For
1h.	Election of Director: K. Ranga Krishnan, MBBS	Management	For	For
1i.	Election of Director: Julia B. North	Management	For	For
1j.	Election of Director: Wayne T. Smith	Management	For	For
1k.	Election of Director: H. James Williams, Ph.D.	Management	For	For
2.	Proposal to approve on an advisory (non-binding) basis the compensation of the Company’s named executive officers.	Management	For	For
3.	Proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For

CSL LTD

Security	Q3018U109	Meeting Type	Annual General Meeting
Ticker Symbol	CSLLY	Meeting Date	17-Oct-2018
Record Date	15-Oct-2018

Item	Proposal	Proposed by	Vote	For/Against Management
CMMT	Please note that this is an amendment to Meeting ID 987749 due to due to deletion of Resolution 1. All votes received on the previous meeting will be disregarded and you will need to reinstruct on this meeting notice. Thank you	Non-voting
CMMT	Voting exclusions apply to this meeting for proposals 2.A., 2.B., 2.C., 3, 4, 5 and 6. Votes cast by any individual or related party who will benefit from the passing of the proposal/s will be disregarded by the Company. Hence, if you have obtained benefit or expect to obtain future benefit (as referred in the Company announcement) vote abstain on the relevant proposal items. By doing so, you acknowledge that you have obtained benefit or expect to obtain benefit by the passing of the relevant proposal/s. By voting (for or against) on the above-mentioned proposal/s, you acknowledge that you have not obtained benefit neither expect to obain benefit by the passing of the relevant proposal/s and you comply with the voting exclusion	Non-voting
2.A	To Elect Dr Brian McNamee Ao As A Director
2.B	To Elect Mr Abbas Hussain As A Director	Management	For	For
2.C	To Elect Dr Andrew Cuthbertson Ao As A Director	Management	For	For
3	Adoption Of The Remuneration Report	Management	For	For
4	Grant Of Performance Share Units To The Chief Executive Officer and Managing Director, Mr Paul Perreault	Management	For	For
5	Re-Approval Of The Global Employee Share Plan	Management	For	For
6	Re-Approval Of The Performance Rights Plan	Management	For	For
CMMT	If a proportional takeover bid is made for the Company, a share transfer to the offer cannot be registered until the bid is approved by members not associated with the bidder. The resolution must be considered at a meeting held more than 14 days before the bid closes. Each member has one vote for each fully paid share held. The vote is decided on a simple majority. The bidder and its associates are not allowed to vote.	Non-voting
7	Rnewal Of Proportional Takeover Approval Provisions in Constitution	Management	For	For

CVS HEALTH CORPORATION

Security	126650100	Meeting Type	Annual
Ticker Symbol	CVS	Meeting Date	16-May-2019
Record Date	21-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Fernando Aguirre	Management	For	For
1b.	Election of Director: Mark T. Bertolini	Management	For	For
1c.	Election of Director: Richard M. Bracken	Management	For	For
1d.	Election of Director: C. David Brown II	Management	For	For
1e.	Election of Director: Alecia A. DeCoudreaux	Management	For	For
1f.	Election of Director: Nancy-Ann M. DeParle	Management	For	For
1g.	Election of Director: David W. Dorman	Management	For	For
1h.	Election of Director: Roger N. Farah	Management	For	For
1i.	Election of Director: Anne M. Finucane	Management	For	For
1j.	Election of Director: Edward J. Ludwig	Management	For	For
1k.	Election of Director: Larry J. Merlo	Management	For	For
1l.	Election of Director: Jean-Pierre Millon	Management	For	For
1m.	Election of Director: Mary L. Schapiro	Management	For	For
1n.	Election of Director: Richard J. Swift	Management	For	For
1o.	Election of Director: William C. Weldon	Management	For	For
1p.	Election of Director: Tony L. White	Management	For	For
2.	Proposal to ratify appointment of independent registered public accounting firm for 2019.	Management	For	For
3.	Say on Pay, a proposal to approve, on an advisory basis, the Company’s executive compensation.	Management	For	For
4.	Stockholder proposal regarding exclusion of legal or compliance costs from financial performance adjustments for executive compensation.	Shareholder	Against	For

DAIICHI SANKYO COMPANY, LIMITED

Security	J11257102	Meeting Type	Annual General Meeting
Ticker Symbol	DSNKY	Meeting Date	17-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Nakayama, Joji	Management	For	For
2.2	Appoint a Director Manabe, Sunao	Management	For	For
2.3	Appoint a Director Sai, Toshiaki	Management	For	For
2.4	Appoint a Director Tojo, Toshiaki	Management	For	For
2.5	Appoint a Director Uji, Noritaka	Management	For	For
2.6	Appoint a Director Fukui, Tsuguya	Management	For	For
2.7	Appoint a Director Kimura, Satoru	Management	For	For
2.8	Appoint a Director Kama, Kazuaki	Management	For	For
2.9	Appoint a Director Nohara, Sawako	Management	For	For
3.1	Appoint a Corporate Auditor Watanabe, Ryoichi	Management	For	For
3.2	Appoint a Corporate Auditor Sato, Kenji	Management	For	For
4	Approve Payment of Bonuses to Directors	Management	For	For

DANAHER CORPORATION

Security	235851102	Meeting Type	Annual
Ticker Symbol	DHR	Meeting Date	07-May-2019
Record Date	11-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Donald J. Ehrlich	Management	For	For
1B.	Election of Director: Linda Hefner Filler	Management	For	For
1C.	Election of Director: Thomas P. Joyce, Jr.	Management	For	For
1D.	Election of Director: Teri List-Stoll	Management	For	For
1E.	Election of Director: Walter G. Lohr, Jr.	Management	For	For
1F.	Election of Director: Mitchell P. Rales	Management	For	For
1G.	Election of Director: Steven M. Rales	Management	For	For
1H.	Election of Director: John T. Schwieters	Management	For	For
1I.	Election of Director: Alan G. Spoon	Management	For	For
1J.	Election of Director: Raymond C. Stevens, Ph.D.	Management	For	For
1K.	Election of Director: Elias A. Zerhouni, M.D.	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as Danaher’s independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For
3.	To approve on an advisory basis the Company’s named executive officer compensation.	Management	For	For
4.	To act upon a shareholder proposal requesting adoption of a policy requiring an independent Board Chair whenever possible.	Shareholder	For	Against

DECIPHER BIOSCIENCES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	28-Jan-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment of Amended and Restated Certificate of Incorporation	Management	For	For
2	Approval of 2019 Bridge Financing	Management	For	For
3	General Authorizing Resolution	Management	For	For

DECIPHER BIOSCIENCES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	21-Mar-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment and Restatement of Certificate of Incorporation	Management	For	For
2	Series 3 Preferred Stock Financing	Management	For	For
3	Amendment of 2018 Equity Incentive Plan	Management	For	For
4	General Authorizing Resolution	Management	For	For

DENTSPLY SIRONA INC.

Security	24906P109	Meeting Type	Annual
Ticker Symbol	XRAY	Meeting Date	22-May-2019
Record Date	25-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Michael C. Alfano	Management	For	For
1b.	Election of Director: Eric K. Brandt	Management	For	For
1c.	Election of Director: Donald M. Casey, Jr.	Management	For	For
1d.	Election of Director: Willie A. Deese	Management	For	For
1e.	Election of Director: Betsy D. Holden	Management	For	For
1f.	Election of Director: Arthur D. Kowaloff	Management	For	For
1g.	Election of Director: Harry M. Kraemer, Jr.	Management	For	For
1h.	Election of Director: Gregory T. Lucier	Management	For	For
1i.	Election of Director: Francis J. Lunger	Management	For	For
1j.	Election of Director: Leslie F. Varon	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for 2019.	Management	For	For
3.	Approval, by non-binding vote, of the Company’s executive compensation.	Management	For	For

DIPLOMAT PHARMACY, INC.

Security	25456K101	Meeting Type	Annual
Ticker Symbol	DPLO	Meeting Date	03-Jun-2019
Record Date	09-Apr-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Kenneth O. Klepper		For	For
	2	Benjamin Wolin		For	For
2.	Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.		Management	For	For
3.	Advisory approval of named executive officer compensation.		Management	For	For

DR. REDDY’S LABORATORIES LIMITED

Security	256135203	Meeting Type	Special
Ticker Symbol	RDY	Meeting Date	24-Mar-2019
Record Date	22-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Special Resolution - To approve continuation of directorship of Dr. Bruce L A Carter (DIN: 02331774) and further re-appoint him as a non-executive independent director for the second term of 3 (three) consecutive years.	Management	For	For

EDWARDS LIFESCIENCES CORPORATION

Security	28176E108	Meeting Type	Annual
Ticker Symbol	EW	Meeting Date	08-May-2019
Record Date	13-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Michael A. Mussallem	Management	For	For
1b.	Election of Director: Kieran T. Gallahue	Management	For	For
1c.	Election of Director: Leslie S. Heisz	Management	For	For
1d.	Election of Director: William J. Link, Ph.D.	Management	For	For
1e.	Election of Director: Steven R. Loranger	Management	For	For
1f.	Election of Director: Martha H. Marsh	Management	For	For
1g.	Election of Director: Wesley W. von Schack	Management	For	For
1h.	Election of Director: Nicholas J. Valeriani	Management	For	For
2.	Advisory Vote To Approve Compensation of Named Executive Officers	Management	For	For
3.	Ratification of the Appointment of Independent Registered Public Accounting Firm	Management	For	For
4.	Advisory Vote On A Stockholder Proporal Regarding An Independent Chair Policy	Shareholder	For	Against

ELI LILLY AND COMPANY

Security	532457108	Meeting Type	Annual
Ticker Symbol	LLY	Meeting Date	06-May-2019
Record Date	26-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of director for three-year term: R. Alvarez	Management	For	For
1b.	Election of director for three-year term: C. R. Bertozzi	Management	For	For
1c.	Election of director for three-year term: J. R. Luciano	Management	For	For
1d.	Election of director for three-year term: K. P. Seifert	Management	For	For
2.	Approval, by non-binding vote, of the compensation paid to the company’s named executive officers.	Management	For	For
3.	Ratification of Ernst & Young LLP as the principal independent auditor for 2019.	Management	For	For
4.	Approve amendments to the Articles of Incorporation to eliminate the classified board structure.	Management	For	For
5.	Approve amendments to the Articles of Incorporation to eliminate all supermajority voting provisions.	Management	For	For
6.	Shareholder proposal requesting a report regarding direct and indirect political expenditures.	Shareholder	Against	For

ENDO INTERNATIONAL PLC

Security	G30401106	Meeting Type	Annual
Ticker Symbol	ENDP	Meeting Date	11-Jun-2019
Record Date	12-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Roger H. Kimmel	Management	For	For
1b.	Election of Director: Paul V. Campanelli	Management	For	For
1c.	Election of Director: Shane M. Cooke	Management	For	For
1d.	Election of Director: Nancy J. Hutson, Ph.D.	Management	For	For
1e.	Election of Director: Michael Hyatt	Management	For	For
1f.	Election of Director: Sharad S. Mansukani, M.D.	Management	For	For
1g.	Election of Director: William P. Montague	Management	For	For
2.	To approve, by advisory vote, named executive officer compensation.	Management	For	For
3.	To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan.	Management	For	For
4.	To renew the Board’s existing authority to issue shares under Irish law.	Management	For	For
5.	To renew the Board’s existing authority to opt-out of statutory pre-emption rights under Irish law.	Management	For	For
6.	To approve the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm’s remuneration.	Management	For	For

EXPRESS SCRIPTS HOLDING COMPANY

Security	30219G108	Meeting Type	Special
Ticker Symbol	ESRX	Meeting Date	24-Aug-2018
Record Date	12-Jul-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1.	A proposal to adopt the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, and as it may be further amended from time to time (the “Merger Agreement”), by and among Cigna Corporation, Express Scripts Holding Company (“Express Scripts”), Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc.	Management	For	For
2.	A proposal to approve the adjournment of the Express Scripts special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the proposal to adopt the Merger Agreement.	Management	For	For
3.	A proposal to approve, by a non-binding advisory vote, certain compensation arrangements that may be paid or become payable to Express Scripts’ named executive officers in connection with the mergers contemplated by the Merger Agreement.	Management	For	For

FOAMIX PHARMACEUTICALS LTD

Security	M46135105	Meeting Type	Annual
Ticker Symbol	FOMX	Meeting Date	10-Apr-2019
Record Date	28-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1	Appoint Kesselman & Kesselman (a member firm of PricewaterhouseCoopers International Limited, or PwC) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019, and authorize the Board (or the Audit Committee, if such authority is delegated to it by the Board) to fix the remuneration of such independent public accountants in accordance with the volume and nature of their services.	Management	For	For
2a	Ratify the election of Mr. Anthony Bruno as a director of the Company.	Management	For	For
2b	Ratify the election of Ms. Sharon Barbari as a director of the Company.	Management	For	For
3a	Approve certain retirement payment and benefits for Dr. Darrell Rigel, as set out in subclause (a) of Proposal 3 of the Company’s proxy statement.	Management	For	For
3a1	For purposes of Proposal 3(a) please confirm that you are NOT a “controlling shareholder” and that you do NOT have a “personal interest” in the approval of Proposal 3(a), as such terms are defined in the Israeli Companies Law. (Note: If you do not mark the ‘FOR’ box, it will be deemed that you are a controlling shareholder and that you do have a personal interest and your vote will not be counted).	Management	For
3b	Approve certain retirement payment and benefits for Dr. Dalia Megiddo, as set out in sub-clause (b) of Proposal 3 of the Company’s proxy statement.	Management	For	For
3b1	For purposes of Proposal 3(b) please confirm that you are NOT a “controlling shareholder” and that you do NOT have a “personal interest” in the approval of Proposal 3(b), as such terms are defined in the Israeli Companies Law. (Note: If you do not mark the ‘FOR’ box, it will be deemed that you are a controlling shareholder and that you do have a personal interest and your vote will not be counted).	Management	For
4	Approve the Company’s 2019 Equity Incentive Plan.	Management	For	For
5	Approve the Company’s 2019 Employee Stock Purchase Plan.	Management	For	For
6a	Approve an increase in Mr. Domzalski’s annual base salary to $560,000, effective January 1, 2019, as set out under sub- clause (a) of Proposal 6 in the Company’s proxy statement.	Management	For	For
6a1	For purposes of Proposal 6(a) please confirm that you are NOT a “controlling shareholder” and that you do NOT have a “personal interest” in the approval of Proposal 6(a), as such terms are defined in the Israeli Companies Law. (Note: If you do not mark the ‘FOR’ box, it will be deemed that you are a controlling shareholder and that you do have a personal interest and your vote will not be counted).	Management	For
6b	Approve the terms of Mr. Domzalski’s cash bonus and equity compensation for 2019, as set out under sub- clause (b) of Proposal 6 of the Company’s proxy statement.	Management	For	For
6b1	For purposes of Proposal 6(b) please confirm that you are NOT a “controlling shareholder” and that you do NOT have a “personal interest” in the approval of Proposal 6(b), as such terms are defined in the Israeli Companies Law. (Note: If you do not mark the ‘FOR’ box, it will be deemed that you are a controlling shareholder and that you do have a personal interest and your vote will not be counted).	Management	For
6c	Approve Mr. Domzalski’s eligibility to participate in the Company’s 2019 Employee Stock Purchase Plan, if approved, as set out under sub-clause (c) of Proposal 6 of the Company’s proxy statement.	Management	For	For
6c1	For purposes of Proposal 6(b) please confirm that you are NOT a “controlling shareholder” and that you do NOT have a “personal interest” in the approval of Proposal 6(b), as such terms are defined in the Israeli Companies Law. (Note: If you do not mark the ‘FOR’ box, it will be deemed that you are a controlling shareholder and that you do have a personal interest and your vote will not be counted).	Management	For
7	Approve an increase of the authorized share capital of the Company from 90,000,000 to 135,000,000 ordinary shares with a nominal value of NIS 0.16 per share and a corresponding amendment to the Articles of Association of the Company.	Management	For	For

GALAPAGOS N V

Security	36315X101	Meeting Type	Annual
Ticker Symbol	GLPG	Meeting Date	30-Apr-2019
Record Date	22-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O2	Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2018 and approval of the allocation of the annual result as proposed by the board of directors.	Management	For	For
O5	Acknowledgement and approval of the remuneration report.	Management	For	For
O6	Release from liability to be granted to the directors and the statutory auditor for the performance of their duties in the course of the financial year ended 31 December 2018.	Management	For	For
O7	Revision of the remuneration of the statutory auditor.	Management	For	For
O8	Appointment of Mr. Peter Guenter as director of the Company.	Management	For	For
O9	Remuneration of directors.	Management	For	For
O10	Offer of warrants.	Management	For	For
S11	Application of article 556 of the Belgian Companies Code.	Management	For	For

GALAPAGOS NV

Security	B44170106	Meeting Type	Annual General Meeting
Ticker Symbol	GLPGF	Meeting Date	30-Apr-2019
Record Date	16-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1	Acknowledgement and Discussion of the Annual Report of Directors Relating to the Non-Consolidated and Consolidated Annual Accounts of the Company for the Financial Year Ended 31 December 2018, and of the Report of the Statutory Auditor Relating to the Non-Consolidated Annual Accounts of the Company for the Financial Year Ended on 31 December 2018.	Non-Voting
2	Acknowledgement and Approval of the Non-Consolidated Annual Accounts of the Company for the Financial Year Edned on 31 December 2018 and Approval of the Allocation of the Annual Result as Proposed by the Board of Directors.	Management	For	For
3	Acknowledgement and Discussion of the Report of the Statutory Auditor Relating to the Consolidated Annual Accounts of the Company for the Financial Year Ended on 31 December 2018.	Non-Voting
4	Acknowledgement and Discussion of the Consolidated Annual Accounts of the Company for the Financial Year Ended on 31 December 2018.	Non-Voting
5	Acknowledge and Approval of the Remuneration Report	Management	For	For
6	Release from Liability to be Granted to the Directors and the Statutory Auditor for the Performance of their Duties in the Course of the Financial Year Ended 31 December 2018.	Management	For	For
7	Revision of the Rumeration of the Statutory Auditor: the Shareholders’ Meeting Resolves to Increase the Annual Remuneration of the Statutory Auditor from EUR 350,000 to (I) EUR 430,000 for its Activities Relating to the Statutory Annual Accounts, the Consolidated Annual Accounts and the Interim Reporting of the Company and its Subsidiaries for the Financial Year Ended 31 December 2018 and (II) EUR 630,000 for its Activities Relating to the Statutory Annual Accounts, the Consolidated Annual Accounts and the Interim Reporting of the Company and its Subsidiaries for the Financial Year Ending 31 December 2018.	Management	For	For
8	Appointment of a Director: The Shareholders’ Meeting Resolves to Appoint Mr. Peter Guenter (Residing in Barcelona, Spain) as Director of the Company, for a Period of Four Years Ending Immediately After the Annual Shareholders’ Meeting to be Held in 2023 and, Upon the Proposal of the Board of Directors and in Accordance with the Advice of the Company’s Nomination and Remuneration Committee, to Appoint Mr. Peter Guenter as an Independent Director as He Meets the Independence Criteria Set Forth in Article 526TER of the Belgian Companies Code.	Management	For	For
9	Remuneration of Directors: Upon Recommendation of the Company’s Nomination and Remuneration Committee, the Shareholders’ Meeting Resolves That (A) the Compensation (Excluding Expenses) of the Non-Executive Directors for the Exercise of Their Mandate is Established as Follows: (I) Chairman of the Board: EUR 80,000 Per Annum; (II) Other Non-Executive Board Members: EUR 40,000 Each Per Annum; (III) Additional Compensation for Membership of a Board Committee: EUR 5,000 Per Annum; (IV) Additional Compensation for the Chairmanship of a Board Committee: EUR 10,000 Per Annum; and (B) A Power of Attorney is Granted to the Board of Directors to Determine the Total Remuneration Package of the Managing Director (CEO) for his Management Function in the Company, It Being Understood That This Remuneration Shall Include a Compensation for the Performance of his Mandate as a Director of the Company.	Management	For	For
10	Offer of Warrants: Upon Recommendation of the Company’s Remuneration Committee, The Shareholders’ Meeting (I) Resolves to Offer 100,000 Warrants to Mr. Onno Van De Stolpe, 15, 0000 Warrants to Dr. Raj Parekh, and 7,500 Warrants Each to of Mr. Howard Rowe, Ms. Katrine Bosley, Dr. Mary Kerr and Mr. Peter Guenter, Under Warrant Plans Created (Or To Be Created) by the Board of Directors for the Benefit of Directors, Employees, and Independent Consultants of Galapagos and its Affiliates Within the Framework of the Authorized Capital (Jointly “Warrant Plan 2019”), the Key Conditions of Which Will Be In Line with Previous Warrant Plans of the Company, (II) Empowers the Managing Director, as well as Any Other Director as Regards the Offer to the Managing Director, to Implement this Offer, and (III) to the Extent Required, Approves the Offer of Warrants to Members of Galapagos’ Executive Committee under Warrant Plan 2019 in Accordance with Galapagos’ Remuneration Policy and Practices. In Accordance with Articles 520TER and 556 of the Belgian Companies Code, the Shareholders’ Meeting Expressly Approves the Particular Provisions that will be included in Warrant Plan 2019 pursuant to which, in Exceptional Circumstances (Including in the Event of a Change in Control of the Company), the Warrants Offered (to the Extent Accepted) Under Warrant Plan 2019 Can Be Exercised Early, Even Before the Third Anniversary of Their Award.	Management	For	For
11	Application of Article 556 of the Belgian Companies Code: Proposed Resolution: In Accordance with Article 556 of the Belgian Companies Code, the Shareholders’ Meeting Resolves to Approve, And to the Extent Required, Ratify All of the Provisions Granting Rights to Third Parties Which Could Affect the Assets of the Company, Or Could Impose an Obligation on the Company, where the Exercise of Those Rights is Depedent on a Public Takeover Bid on the Shares of the Company or a Change of Control in Respect of the Company, as Included in: (A) The Second Amended and Restated Collaboration Agreement Between Galapagos NV and Abbvie S.A.R.L. Dated 24 October 2018 (The “Abbvie Agreement”) Including, But Not Limited To, Clause 11.2 (Change in Control of Galapagos) of the Abbvie Agreement, Entitling the Counterparty, in the Event of A Change in Control of the Company, to Oblige the Company to Take Appropriate Measures to Avoid the Disclosure of Confidential Information, to Limit Abbvie’s Reporting Obligations to the Company, or, Depending on the Stage in Which the Change of Control Occurs, to Terminate the Abbvie Agreement; (B) The Exclusive License Agreement Among Galapagos NV, Morphosys AG and Novartis Pharma AG Dated 19 July 2019 (the “Novartis Agreement”), Including, But Not Limited To, Clause 3.7 of the Novartis Agreement (Change of Control), Entitling Novartis, in the Event of a Change of Control of the Company, to Have The Company’s Representatives Removed from the Joint Committees; And (C) the Product Development, License And Commercialization Agreement Between Galapagos NV, Les Laboratoires Servier and Institut de Recherches Servier as Amended and Restated 8 May 2018 (The “Servier Agreement”), Including But Not Limited To Clause 13.4 (Termination by Servier Without Cause or Due to Galapagos Change of Control), Clause 13.5 (Rights on Termination) and Clause 13.7 (Change of Control), Entitling the Counterparty, In the Event of a Change of Control of the Company, To Elect to Terminate the Servier Agreement Subject to an Option for the Company to Choose from Two Contractual Termination Regimes, Both Including The Termination of the Licenses Granted by the Company to Servier and the Freedom for the Company to Conduct Research and Development Activities on Terminated Licensed Products, or to Have The Licenses Granted to Servier Continue, With All Payment Obligations Remaining in Place, but with Servier Having Full Control Over the Further Development and Patent Strategies for the Licensed Product in Servier’s Territory. The Shareholders’ Meeting Grants a Special Power of Attorney to Each Director of the Company, as well as to Mr. Xavier Maes, Ms. Ellen Lefever, Ms. Anneslies Denecker, and Ms. Lauran Diependaele, Each Acting Individually and with the Power of Substitution, to File this Resolution with the Clerk’s Office of the Commercial Court of Antwerp, Division of Mechelen, in Accordance with Article 556 of the Belgian Companies Code.	Management	For	For
12	Miscellaneous	Non-Voting

GALARA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	18-Sep-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Royalty Interest Financing	Management	For	For

GALARA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	6-Nov-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment to Royalty Interest Agreement	Management	For	For

GALARA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	22-Mar-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Election of Kevin Loaky to the Board of Directors	Management	For	For
2	General Enabling Resolutions	Management	For	For

GENMAB A/S

Security	K3967W102	Meeting Type	Annual General Meeting
Ticker Symbol	GNMSF	Meeting Date	29-Mar-2019
Record Date	22-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1	Report by the Board of Directors on the Company’s Activities during the year.	Non-Voting
2	Adoption of the Audited Annual Report and discharge of the Board of Directors and the Executive Management	Management	For	For
3	Deceision as to the Distribution of Profit according to the adopted Annual Report	Management	For	For
4.A	Re-election of Mats Pettersson as a Board of Director	Management	For	For
4.B	Re-Election of Deirdre P. Connelly as a Board of Director	Management	For	For
4.C	Re- Election of Pernille Erenbjerg as a Board of Director	Management	For	For
4.D	Re-election of Rolf Hoffman as a Board of Director	Management	For	For
4.E	Re-election of Dr. Paolo Paoletti as a Board of Director	Management	For	For
4.F	Re-Election of Dr. Anders Gersel Pedersen as a Board of Director	Management	For	For
5	Re-election of PricewaterhouseCoopers STATSAUTORISERET REVISIONSPARTNERSELSKAB as an auditor	Management	For	For
6.A	Proposals from the Board of Directors: Amendment of the Remuneration Principles for the Board of Directors and the Executive Management	Management	For	For
6.B	Proposals from the Board of Directors: Approval of the Board of Directors’ remuneration for 2019	Management	For	For
6.C	Proposals from the Board of Directors: Amendment of Article 5 (Authorization to Issue Warrants)	Management	For	For
6.D	Proposals from the Board of Directors: Authorization of the Board of Directors to Acquire Treasury Shares	Management	For	For
7	Authorization of the Chairman of the General Meeting to register resolutions passed by the General Meeting	Management	For	For
8	Miscellaneous	Non-Voting

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	20-Jul-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment and Restatement of Certification of Incorporation	Management	For	For
2	Second Series E Preferred Stock Financing	Management	For	For
3	Approval of 2018 Equity Incentive Plan	Management	For	For
4	General Authorizing Resolution	Management	For	For

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	3-Oct-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment and Restatement of Certification of Incorporation	Management	For	For
2	Second Series E Preferred Stock Financing	Management	For	For
3	Board Composition	Management	For	For
4	General Authorizing Resolution	Management	For	For

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	19-Nov-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approval of Amendment and Restatement of Certificate of Incorporation	Management	For	For
2	General Authorization	Management	For	For

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	28-Dec-2018
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approval of Note Financing	Management	For	For
2	General Authorizing Resolution	Management	For	For

GILEAD SCIENCES, INC.

Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	08-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Jacqueline K. Barton, Ph.D.	Management	For	For
1b.	Election of Director: John F. Cogan, Ph.D.	Management	For	For
1c.	Election of Director: Kelly A. Kramer	Management	For	For
1d.	Election of Director: Kevin E. Lofton	Management	For	For
1e.	Election of Director: Harish M. Manwani	Management	For	For
1f.	Election of Director: Daniel P. O’Day	Management	For	For
1g.	Election of Director: Richard J. Whitley, M.D.	Management	For	For
1h.	Election of Director: Gayle E. Wilson	Management	For	For
1i.	Election of Director: Per Wold-Olsen	Management	For	For
2.	To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2019.	Management	For	For
3.	To approve an amendment to Gilead’s Restated Certificate of Incorporation to allow stockholders to act by written consent.	Management	For	For
4.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.	Management	For	For
5.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.	Shareholder	For	Against
6.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board issue a report describing how Gilead plans to allocate tax savings as a result of the Tax Cuts and Jobs Act.	Shareholder	Against	For

GLAXOSMITHKLINE PLC

Security	37733W105	Meeting Type	Annual
Ticker Symbol	GSK	Meeting Date	08-May-2019
Record Date	29-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
A1	To receive and adopt the 2018 Annual Report	Management	For	For
A2	To approve the Annual report on remuneration	Management	For	For
A3	To elect Iain Mackay as a Director	Management	For	For
A4	To re-elect Philip Hampton as a Director	Management	For	For
A5	To re-elect Emma Walmsley as a Director	Management	For	For
A6	To re-elect Vindi Banga as a Director	Management	For	For
A7	To re-elect Dr Hal Barron as a Director	Management	For	For
A8	To re-elect Dr Vivienne Cox as a Director	Management	For	For
A9	To re-elect Lynn Elsenhans as a Director	Management	For	For
A10	To re-elect Dr Laurie Glimcher as a Director	Management	For	For
A11	To re-elect Dr Jesse Goodman as a Director	Management	For	For
A12	To re-elect Judy Lewent as a Director	Management	For	For
A13	To re-elect Urs Rohner as a Director	Management	For	For
A14	To re-appoint the auditor	Management	For	For
A15	To determine remuneration of the auditor	Management	For	For
A16	To authorise the company and its subsidiaries to make donations to political organisations and incur political expenditure	Management	For	For
A17	To authorise allotment of shares	Management	For	For
A18	To disapply pre-emption rights - general power (special resolution)	Management	For	For
A19	To disapply pre-emption rights - in connection with an acquisition or specified capital investment (special resolution)	Management	For	For
A20	To authorise the company to purchase its own shares (special resolution)	Management	For	For
A21	To authorise exemption from statement of name of senior statutory auditor	Management	For	For
A22	To authorise reduced notice of a general meeting other than an AGM (special resolution)	Management	For	For
1	To approve the transaction between GlaxoSmithKline plc, GlaxoSmithKline Consumer Healthcare Holdings Limited and Pfizer, Inc for the purposes of Chapter 11 of the Listing Rules of the Financial Conduct Authority	Management	For	For

GLOBAL MEDICAL REIT INC.

Security	37954A204	Meeting Type	Annual
Ticker Symbol	GMRE	Meeting Date	29-May-2019
Record Date	04-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Jeffrey M. Busch	Management	For	For
1.2	Election of Director: Matthew Cypher	Management	For	For
1.3	Election of Director: Zhang Jingguo	Management	For	For
1.4	Election of Director: Ronald Marston	Management	For	For
1.5	Election of Director: Roscoe Moore, Jr.	Management	For	For
1.6	Election of Director: Henry E. Cole	Management	For	For
1.7	Election of Director: Zhang Huiqi	Management	For	For
1.8	Election of Director: Paula R. Crowley	Management	For	For
1.9	Election of Director: Lori Wittman	Management	For	For
2.	Advisory vote to approve the compensation of the Company’s named executive officers.	Management	For	For
3.	To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,000,000.	Management	For	For
4.	To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For

HCA HEALTHCARE, INC.

Security	40412C101	Meeting Type	Annual
Ticker Symbol	HCA	Meeting Date	26-Apr-2019
Record Date	07-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Thomas F. Frist III	Management	For	For
1b.	Election of Director: Samuel N. Hazen	Management	For	For
1c.	Election of Director: Meg G. Crofton	Management	For	For
1d.	Election of Director: Robert J. Dennis	Management	For	For
1e.	Election of Director: Nancy-Ann DeParle	Management	For	For
1f.	Election of Director: William R. Frist	Management	For	For
1g.	Election of Director: Charles O. Holliday, Jr.	Management	For	For
1h.	Election of Director: Geoffrey G. Meyers	Management	For	For
1i.	Election of Director: Michael W. Michelson	Management	For	For
1j.	Election of Director: Wayne J. Riley, M.D.	Management	For	For
1k.	Election of Director: John W. Rowe, M.D.	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	To approve amendments to our amended and restated certificate of incorporation to eliminate supermajority voting requirements.	Management	For	For

HCP, INC.

Security	40414L109	Meeting Type	Annual
Ticker Symbol	HCP	Meeting Date	25-Apr-2019
Record Date	04-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Brian G. Cartwright	Management	For	For
1b.	Election of Director: Christine N. Garvey	Management	For	For
1c.	Election of Director: R. Kent Griffin, Jr.	Management	For	For
1d.	Election of Director: David B. Henry	Management	For	For
1e.	Election of Director: Thomas M. Herzog	Management	For	For
1f.	Election of Director: Lydia H. Kennard	Management	For	For
1g.	Election of Director: Katherine M. Sandstrom	Management	For	For
2.	Approval, on an advisory basis, of 2018 executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as HCP’s independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For

HEALTHCARE REALTY TRUST INCORPORATED

Security	421946104	Meeting Type	Annual
Ticker Symbol	HR	Meeting Date	14-May-2019
Record Date	15-Mar-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	David R. Emery		For	For
	2	Todd J. Meredith		For	For
	3	John V. Abbott		For	For
	4	Nancy H. Agee		For	For
	5	Edward H. Braman		For	For
	6	Peter F. Lyle, Sr.		For	For
	7	John Knox Singleton		For	For
	8	Bruce D. Sullivan		For	For
	9	Christann M. Vasquez		For	For
2.	To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company’s 2019 fiscal year.		Management	For	For
3.	To vote to approve, on a non-binding advisory basis, a resolution approving the Company’s compensation of its Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s Proxy Statement for the 2019 Annual Meeting of Shareholders.		Management	For	For

HEALTHCARE TRUST OF AMERICA, INC.

Security	42225P501	Meeting Type	Annual
Ticker Symbol	HTA	Meeting Date	09-Jul-2019
Record Date	18-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Scott D. Peters	Management	For	For
1b.	Election of Director: W. Bradley Blair, II	Management	For	For
1c.	Election of Director: Vicki U. Booth	Management	For	For
1d.	Election of Director: Maurice J. DeWald	Management	For	For
1e.	Election of Director: Warren D. Fix	Management	For	For
1f.	Election of Director: Peter N. Foss	Management	For	For
1g.	Election of Director: Daniel S. Henson	Management	For	For
1h.	Election of Director: Larry L. Mathis	Management	For	For
1i.	Election of Director: Gary T. Wescombe	Management	For	For
2.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers.	Management	For	For
3.	The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For

HIKMA PHARMACEUTICALS PLC

Security	G4576K104	Meeting Type	Annual General Meeting
Ticker Symbol	HKMPF	Meeting Date	17-May-2019
Record Date

Item	Proposal	Proposed by	Vote	For/Against Management
1	To receive the accounts for the financial year ended 31 December 2018, together with the reports of the Directors and Auditors thereon	Management	For	For
2	To declare a final dividend of 26 cents per ordinary share in respect of the year ended 31 December 2018	Management	For	For
3	To re-appoint PricewaterhouseCoopers LLC as Auditors of the Company	Management	For	For
4	To authorise the Audit Committee to determine the Auditors’ remuneration	Management	For	For
5	To re-elect Said Darwazah as a Director of the Company	Management	For	For
6	To re-elect Siggi Olafsson as Director of the Company	Management	For	For
7	To re-elect Mazen Darwazah as Director of the Company	Management	For	For
8	To re-elect Robert Pickering as a Director of the Company	Management	For	For
9	To re-elect Ali Al-Husry as a Director of the Company	Management	For	For
10	To re-elect Patrick Butler as a Director of the Company	Management	For	For
11	To re-elect Dr. Pamela Kirby as a Director of the Company	Management	For	For
12	To re-elect Dr. Jochen Gann as a Director of the Company	Management	For	For
13	To re-elect John Castellani as a Director of the Company	Management	For	For
14	To re-elect Nina Henderson as a Director of the Company	Management	For	For
15	To receive and approve the Remuneration Committee Report for the financial year ended 31 December 2018	Management	For	For
16	Authorise Directors to allot shares up to an aggregate nominal amount of GBP 8,054,329	Management	For	For
17	That subject to passing Resolution 16 above, the Directors be empowered to allot equity securities for cash on a non pre-emptive basis up to the aggregate nominal amount of GBP 1,208,149	Management	For	For
18	That subject to passing Resolution 16, the authorite under Resolution 17 be further extended to an aggregate nominal amount of GBP 1,208,149 to be used only for the purpose of financing a transaction which is determined to be an acquisition or other capital investment	Management	For	For
19	Grant authority to make market purchases of own shares, up to GBP 2,416,298 representing 10% of the issued share capital of the company	Management	For	For
20	That a General Meeting of Shareholders of the Company other than an Annual General Meeting may be called on not less than 14 clear days’ notice	Management	For	For

HOLOGIC, INC.

Security	436440101	Meeting Type	Annual
Ticker Symbol	HOLX	Meeting Date	07-Mar-2019
Record Date	07-Jan-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Stephen P. MacMillan		For	For
	2	Sally W. Crawford		For	For
	3	Charles J. Dockendorff		For	For
	4	Scott T. Garrett		For	For
	5	Ludwig N. Hantson		For	For
	6	Namal Nawana		For	For
	7	Christiana Stamoulis		For	For
	8	Amy M. Wendell		For	For
2.	A non-binding advisory resolution to approve executive compensation.		Management	For	For
3.	Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2019.		Management	For	For

HOYA CORPORATION

Security	J22848105	Meeting Type	Annual General Meeting
Ticker Symbol	HOCPF	Meeting Date	26-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Uchinaga, Yukako	Management	For	For
1.2	Appoint a Director Urano, Mitsudo	Management	For	For
1.3	Appoint a Director Takasu, Takeo	Management	For	For
1.4	Appoint a Director Kaihori, Shuzo	Management	For	For
1.5	Appoint a Director Yoshihara, Hiroaki	Management	For	For
1.6	Appoint a Director Suzuki, Hiroshi	Management	For	For

HUMANA INC.

Security	444859102	Meeting Type	Annual
Ticker Symbol	HUM	Meeting Date	18-Apr-2019
Record Date	25-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a)	Election of Director: Kurt J. Hilzinger	Management	For	For
1b)	Election of Director: Frank J. Bisignano	Management	For	For
1c)	Election of Director: Bruce D. Broussard	Management	For	For
1d)	Election of Director: Frank A. D’Amelio	Management	For	For
1e)	Election of Director: Karen B. DeSalvo, M.D.	Management	For	For
1f)	Election of Director: W. Roy Dunbar	Management	For	For
1g)	Election of Director: David A. Jones, Jr.	Management	For	For
1h)	Election of Director: William J. McDonald	Management	For	For
1i)	Election of Director: James J. O’Brien	Management	For	For
1j)	Election of Director: Marissa T. Peterson	Management	For	For
2.	The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.	Management	For	For
3.	The approval of the compensation of the named executive officers as disclosed in the 2019 proxy statement.	Management	For	For
4.	The approval of the Amended and Restated Humana Inc. Stock Incentive Plan.	Management	For	For

IDEXX LABORATORIES, INC.

Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	08-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Jonathan W. Ayers	Management	For	For
1b.	Election of Director: Stuart M. Essig, PhD	Management	For	For
1c.	Election of Director: M. Anne Szostak	Management	For	For
2.	Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year.	Management	For	For
3.	Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company’s executive compensation.	Management	For	For

ILLUMINA, INC.

Security	452327109	Meeting Type	Annual
Ticker Symbol	ILMN	Meeting Date	29-May-2019
Record Date	01-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Frances Arnold, Ph.D.	Management	For	For
1B.	Election of Director: Francis A. deSouza	Management	For	For
1C.	Election of Director: Susan E. Siegel	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2019.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.	Management	For	For
4.	To approve an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors.	Management	For	For
5.	To approve, on an advisory basis, a stockholder proposal to enhance election-related disclosures.	Shareholder	Against	For

ILLUMINOSS MEDICAL, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	5-Mar-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approval of Equity Incentive Plan	Management	For	For
2	Anti-Dilution	Management	For	For
3	General Resolutions	Management	For	For

INCYTE CORPORATION

Security	45337C102	Meeting Type	Annual
Ticker Symbol	INCY	Meeting Date	26-Apr-2019
Record Date	12-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Julian C. Baker	Management	For	For
1.2	Election of Director: Jean-Jacques Bienaimé	Management	For	For
1.3	Election of Director: Paul A. Brooke	Management	For	For
1.4	Election of Director: Paul J. Clancy	Management	For	For
1.5	Election of Director: Wendy L. Dixon	Management	For	For
1.6	Election of Director: Jacqualyn A. Fouse	Management	For	For
1.7	Election of Director: Paul A. Friedman	Management	For	For
1.8	Election of Director: Hervé Hoppenot	Management	For	For
2.	To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.	Management	For	For
3.	To approve amendments to the Company’s Amended and Restated 2010 Stock Incentive Plan.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2019.	Management	For	For
5.	To vote on a stockholder proposal, if properly presented, described in more detail in the proxy statement.	Shareholder	For	Against

INNATE PHARMA SA

Security	F5277D100	Meeting Type	MIX
Ticker Symbol	IPHYF	Meeting Date	22-May-2019
Record Date	17-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O.1	Approval of the Corporate Financial Statements for the financial year ended 31 December 2018.	Management	For	For
O.2	Approval of the Consolidated Financial Statements for the financial year ended 31 December 2018	Management	For	For
O.3	Allocation of income for the financial year ended 31 December 2018	Management	For	For
O.4	Regulated Agreements and Commitments	Management	For	For
O.5	Renewal of Mr. Herve Brailly as member of the Supervisory Board	Management	For	For
O.6	Renewal of Mr. Gilles Brisson as member of the Supervisory Board	Management	For	For
O.7	Renewal of Mrs. Irina Staatz Granzer as member of the Supervisory Board	Management	For	For
O.8	Renewal of NOVO NORDISK A/S COMPANY as member of the Supervisory Board	Management	For	For
O.9	Renewal of Mrs. Veronique Chabernaud as member of the Supervisory Board	Management	For	For
O.10	Renewal of Mr. Patrick Langlois as member of the Supervisory Board	Management	For	For
O.11	Renewal of BPIFRANCE PARTICIPATIONS as member of the Supervisory Board	Management	For	For
O.12	Renewal of Mr. Jean-Yves Blay as member of the Supervisory Board	Management	For	For
O.13	Renewal of Mr. Oliver Martinez as Censor of the Supervisor Board	Management	For	For
O.14	Setting the attendance fees to be allocated to members of the Supervisory Board	Management	For	For
O.15	Approval of the principles and criteria for determining, distributing and allocating fixed, variable and exceptional elements making up the total compensation and benefits of any kind attributable to the Chairman of the Management Board for the financial year 2019	Management	For	For
O.16	Approval of the principles and criteria for determining, distributing and allocating fixed, variable and exceptional elements making up the total compensation and beneits of any kind attributable to the members of the Management Board for the financial year 2019	Management	For	For
O.17	Approval of the principles and criteria for determining, distributing and allocating fixed, variable and exceptional elements making up the total compensation and beneits of any kind attributable to the Chairman of the Supervisory Board for the financial year 2019	Management	For	For
O.18	Approval of the principles and criteria for determining, distributing and allocating fixed, variable and exceptional elements making up the total compensation and beneits of any kind attributable to the members of the Supervisory Board for the financial year 2019	Management	For	For
O.19	Approval of fixed, variable, exceptional elements making up the total compensation and benefits of any kind paid or allocated to the Chairman of the Management Board for the financial year 2018	Management	For	For
O.20	Approval of fixed, variable, exceptional elements making up the total compensation and benefits of any kind paid or allocated to the Mr. Yannis Morel as a member of the Management Board for the financial year 2018	Management	For	For
O.21	Approval of fixed, variable, exceptional elements making up the total compensation and benefits of any kind paid or allocated to the Chairman of the Supervisory Board for the financial year 2018	Management	For	For
O.22	Authorization to allow the Company to buy back its own shares	Management	For	For
E.23	Authorization granted to the Management Board to proceed with free allocations of existing shares or shares to be issues to new executives (employees and/or corporate officers) of the Company or its subsidiaries	Management	For	For
E.24	Authorization granted to the Management Board to proceed with free allocations of existing shares or shares to be issued for the benefit of the members of the salaried Executive Committee, salaried Senior Executives and/or Corporate Officers of the Company or its subsidiaries for their annual variable compensation	Management	For	For
E.25	Authorization granted to the Management Board to proceed with free allocations of existing shares or shares to be issued on the basis of the achievement of performance criteria for the benefit of salaried Managers, members of the salaried Executive Committee, salaried Senior Executives and/or Corporate Officers of the Company or its subsidiaries	Management	For	For
E.26	Authorization granted to the Management Board to proceed with free allocations of existing shares or shares to be issued on the basis of the achievement of performance criteria for the benefit of employees of the Company or its subsidiaries	Management	For	For
E.27	Delegation of authority to the Management Board to issue ordinary shares of the Company and/or transferable securities granting access to the capital of the Company, with retention of the pre-emptive subscription right of the Shareholders	Management	For	For
E.28	Delegation of authority to the Management Board to issue ordinary shares of the Company and/or transferable securities granting access to the capital of the Company, with cancellation of the Shareholders’ pre-emptive sunscription right, by a Public Offering	Management	For	For
E.29	Delegation of authority to the Management Board to issue ordinary shares of the Company and/or transferable securities granting access to the capital of the Company, with cancellation of the pre-emptive subscription right of the Shareholders, in the context of an offer referred to in Section 11 of Article L. 411-2 of the French Monetary and Financial Code	Management	For	For
E.30	Setting the issue price of the Ordinary Shares and/or any transferable securities granting access to the capital, in case of cancellation of the pre-emptive subscription right, within the annual limit of 10% of the capital	Management	For	For
E.31	Delegation of authority to the Management Board to issue ordinary shres of the Company and/or transferable securities granting access to the Company’s capital, with cancellation of the Shareholders’ pre-emptive subscription right and for the benefit of categories of persons	Management	For	For
E.32	Authorization granted to the Management Board in the event of a capital increase, with or without the cancellation of the Shareholders’ pre-emptive right, to increase the number of securities to be issued by 15%	Management	For	For
E.33	Delegation of powers to the Management Board to issue ordinary shares and/or transferable securities granting access to the Company’s capital in consideration of contributions in kind consisting of equity securities or transferable securities granting access to the capital	Management	For	For
E.34	Delegation of authority to the Management Board to issue ordinary shares and/or transferable securities granting access to the Company’s capital, in the event of a Public Exchange Offer initiated by the Company	Management	For	For
E.35	Overall limitation of authorizations provided for in resolutions 27 to 29 and 31 to 35 above	Management	For	For
E.36	Delegation of authority to the Management Board to issue ordinary shares and/or transferable securities granting access to the capital of the Company for the benefit of members of a Company Savings Plan	Management	For	For
E.37	Delegation of authority granted to the Management Board with a view to canceling all or poart of the shares held by the Company pursuant to the share buyback authorization	Management	For	For
E.38	Amendment to Article 27 of the Bylaws to allow the General Meetings to be held in Paris	Management	For	For
E.39	Powers for completion of formalities	Management	For	For

INTUITIVE SURGICAL, INC.

Security	46120E602	Meeting Type	Annual
Ticker Symbol	ISRG	Meeting Date	25-Apr-2019
Record Date	01-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Craig H. Barratt, Ph.D.	Management	For	For
1b.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1c.	Election of Director: Amal M. Johnson	Management	For	For
1d.	Election of Director: Don R. Kania, Ph.D.	Management	For	For
1e.	Election of Director: Keith R. Leonard, Jr.	Management	For	For
1f.	Election of Director: Alan J. Levy, Ph.D.	Management	For	For
1g.	Election of Director: Jami Dover Nachtsheim	Management	For	For
1h.	Election of Director: Mark J. Rubash	Management	For	For
1i.	Election of Director: Lonnie M. Smith	Management	For	For
2.	To approve, by advisory vote, the compensation of the Company’s Named Executive Officers.	Management	For	For
3.	The ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
4.	To approve the amendment and restatement of the 2010 Incentive Award Plan.	Management	For	For
5.	A stockholder proposal entitled “Simple Majority Vote.”	Shareholder	Against	For

IQVIA HOLDINGS INC.

Security	46266C105	Meeting Type	Annual
Ticker Symbol	IQV	Meeting Date	09-Apr-2019
Record Date	14-Feb-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1	DIRECTOR		Management
	1	Carol J. Burt		For	For
	2	John P. Connaughton		For	For
	3	John G. Danhakl		For	For
	4	James A. Fasano		For	For
2	The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.’s independent registered public accounting firm for the year ending December 31, 2019.		Management	For	For

JOHNSON & JOHNSON

Security	478160104	Meeting Type	Annual
Ticker Symbol	JNJ	Meeting Date	25-Apr-2019
Record Date	26-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Mary C. Beckerle	Management	For	For
1b.	Election of Director: D. Scott Davis	Management	For	For
1c.	Election of Director: Ian E. L. Davis	Management	For	For
1d.	Election of Director: Jennifer A. Doudna	Management	For	For
1e.	Election of Director: Alex Gorsky	Management	For	For
1f.	Election of Director: Marillyn A. Hewson	Management	For	For
1g.	Election of Director: Mark B. McClellan	Management	For	For
1h.	Election of Director: Anne M. Mulcahy	Management	For	For
1i.	Election of Director: William D. Perez	Management	For	For
1j.	Election of Director: Charles Prince	Management	For	For
1k.	Election of Director: A. Eugene Washington	Management	For	For
1l.	Election of Director: Ronald A. Williams	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
3.	Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2019.	Management	For	For
4.	Shareholder Proposal - Clawback Disclosure	Shareholder	Against	For
5.	Shareholder Proposal - Executive Compensation and Drug Pricing Risks.	Shareholder	Against	For

KONINKLIJKE PHILIPS ELECTRONICS N.V.

Security	500472303	Meeting Type	Annual
Ticker Symbol	PHG	Meeting Date	09-May-2019
Record Date	11-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
2c.	Proposal to adopt the financial statements	Management	For
2d.	Proposal to adopt dividend	Management	For
2e.	Proposal to discharge the members of the Board of Management	Management	For
2f.	Proposal to discharge the members of the Supervisory Board	Management	For
3a.	Composition of the Board of Management: Proposal to re-appoint Mr F.A. van Houten as President/Chief Executive Officer and member of the Board of Management	Management	For
3b.	Composition of the Board of Management: Proposal to re-appoint Mr A. Bhattacharya as member of the Board of Management	Management	For
4a.	Composition of the Supervisory Board: Proposal to re- appoint Mr D.E.I. Pyott as member of the Supervisory Board	Management	For
4b.	Composition of the Supervisory Board: Proposal to appoint Ms E. Doherty as member of the Supervisory Board	Management	For
5.	Proposal to re-appoint Ernst & Young Accountants LLP as the external auditor of the company	Management	For
6a.	Proposal to authorize the Board of Management to: issue shares or grant rights to acquire shares	Management	For
6b.	Proposal to authorize the Board of Management to: restrict or exclude preemption rights	Management	For
7.	Proposal to authorize the Board of Management to acquire shares in the company	Management	For
8.	Proposal to cancel shares	Management	For

LABORATORY CORP. OF AMERICA HOLDINGS

Security	50540R409	Meeting Type	Annual
Ticker Symbol	LH	Meeting Date	09-May-2019
Record Date	22-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kerrii B. Anderson	Management	For	For
1b.	Election of Director: Jean-Luc Bélingard	Management	For	For
1c.	Election of Director: D. Gary Gilliland, M.D., Ph.D.	Management	For	For
1d.	Election of Director: David P. King	Management	For	For
1e.	Election of Director: Garheng Kong, M.D., Ph.D.	Management	For	For
1f.	Election of Director: Peter M. Neupert	Management	For	For
1g.	Election of Director: Richelle P. Parham	Management	For	For
1h.	Election of Director: Adam H. Schechter	Management	For	For
1i.	Election of Director: R. Sanders Williams, M.D.	Management	For	For
2.	To approve, by non-binding vote, executive compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as Laboratory Corporation of America Holdings’ independent registered public accounting firm for 2019.	Management	For	For

LIVANOVA PLC

Security	G5509L101	Meeting Type	Annual
Ticker Symbol	LIVN	Meeting Date	18-Jun-2019
Record Date	25-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Mr. Francesco Bianchi	Management	For	For
1b.	Election of Director: Ms. Stacy Enxing Seng	Management	For	For
1c.	Election of Director: Mr. William A. Kozy	Management	For	For
1d.	Election of Director: Mr. Damien McDonald	Management	For	For
1e.	Election of Director: Mr. Daniel J. Moore	Management	For	For
1f.	Election of Director: Mr. Hugh M. Morrison	Management	For	For
1g.	Election of Director: Mr. Alfred J. Novak	Management	For	For
1h.	Election of Director: Dr. Sharon O’Kane	Management	For	For
1i.	Election of Director: Dr. Arthur L. Rosenthal	Management	For	For
1j.	Election of Director: Ms. Andrea L. Saia	Management	For	For
2.	To approve, on an advisory basis, LivaNova’s compensation of its named executive officers (“US Say- on-Pay”)	Management	For	For
3.	To ratify PricewaterhouseCoopers LLP, a Delaware limited liability partnership (“PwC USA”) as the Company’s independent registered public accountancy firm	Management	For	For
4.	To approve, on an advisory basis, the U.K. directors’ remuneration report in the form set out in the Company’s U.K. annual report and accounts (“U.K. Annual Report”) for the period ended 31 December, 2018	Management	For	For
5.	To approve the directors’ Remuneration Policy as set out in the UK Annual Report for the period ended 31 December 2018	Management	For	For
6.	To receive and adopt the Company’s audited UK statutory accounts for the year ended December 31, 2018, together with the reports of the directors and the auditors thereon	Management	For	For
7.	To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership registered in England, (“PwC UK”), as the Company’s UK statutory auditor	Management	For	For
8.	To authorize the directors and/or the Audit and Compliance Committee to determine the UK statutory auditor’s remuneration	Management	For	For

LONZA GROUP AG

Security	H50524133	Meeting Type	Annual General Meeting
Ticker Symbol	LZAGF	Meeting Date	18-Apr-2019
Record Date	04-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1	Annual Report, Consolidated Financial Statements and Financial Statements of Lonza	Management	For	For
2	Consultative vote on the Remuneration Report	Management	For	For
3	Discharge of the members of the Board of Directors and the Executive Committee	Management	For	For
4	Appropriation of available earnings/reserves from capital contribution: if the above proposal for appropriation of available earnings and distribution of reserves from capital contributioons is approved, the divided of CHF 2.75 per share (as repayment from reserves from capital contribution) will be paid without deduction of Swiss Withholding Tax in accordance with ART. 5 PARA. 1BIS of the Federal Law on Withholding Tax	Management	For	For
5.1.A	Re-election of the following individual to the Board of Directors: PATRICK AEBISCHER	Management	For	For
5.1.B	Re-election of the following individual to the Board of Directors: WERNER BAUER	Management	For	For
5.1.C	Re-election of the following individual to the Board of Directors: ALBERT M. BAEHNY	Management	For	For
5.1.D	Re-election of the following individual to the Board of Directors: ANGELICA KOHLMANN	Management	For	For
5.1.E	Re-election of the following individual to the Board of Directors: CHRISTOPH MADER	Management	For	For
5.1.F	Re-election of the following individual to the Board of Directors: BARBARA RICHMOND	Management	For	For
5.1.G	Re-election of the following individual to the Board of Directors: MARGOT SCHELTEMA	Management	For	For
5.1.H	Re-election of the following individual to the Board of Directors: JURGEN STEINEMANN	Management	For	For
5.1.I	Re-election of the following individual to the Board of Directors: OLIVIER VERSCHEURE	Management	For	For
5.2	Re-election of the Chairperson to the Board of Directors: ALBERT M. BAEHNY	Management	For	For
5.3.A	Re-election of the following individual to the Nomination and Compensation Committee: ANGELICA KOHLMANN	Management	For	For
5.3.B	Re-election of the following individual to the Nomination and Compensation Committee: CHRISTOPH MADER	Management	For	For
5.3.C	Re-election of the following individual to the Nomination and Compensation Committee: JURGEN STEINEMANN	Management	For	For
6	Re-election of the Auditors: KPMG LTD, Zurich, Switzerland	Management	For	For
7	Re-election of the Independent Proxy: DANIEL PLUSS	Management	For	For
8	Compensation of the Board of Directors	Management	For	For
9.1	Compensation of the Executive Committee: maximum aggregate amount of fixed compensation of the Executive Committee	Management	For	For
9.2	Compensation of the Executive Committee: maximum aggregate amount of variable short-term compensation of the Executive Committee	Management	For	For
9.3	Compensation of the Executive Committee: maximum aggregate amount of variable long-term compensation of the Executive Committee	Management	For	For
10	Renewal of authorized capital: Article 4TER of the Articles of Association	Management	For	For

LTC PROPERTIES, INC.

Security	502175102	Meeting Type	Annual
Ticker Symbol	LTC	Meeting Date	29-May-2019
Record Date	15-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Boyd W. Hendrickson	Management	For	For
1.2	Election of Director: James J. Pieczynski	Management	For	For
1.3	Election of Director: Devra G. Shapiro	Management	For	For
1.4	Election of Director: Wendy L. Simpson	Management	For	For
1.5	Election of Director: Timothy J. Triche, M.D.	Management	For	For
2.	Ratification of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For

MALLINCKRODT PLC

Security	G5785G107	Meeting Type	Annual
Ticker Symbol	MNK	Meeting Date	15-May-2019
Record Date	11-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: David R. Carlucci	Management	For	For
1b.	Election of Director: J. Martin Carroll	Management	For	For
1c.	Election of Director: Paul R. Carter	Management	For	For
1d.	Election of Director: David Y. Norton	Management	For	For
1e.	Election of Director: JoAnn A. Reed	Management	For	For
1f.	Election of Director: Angus C. Russell	Management	For	For
1g.	Election of Director: Mark C. Trudeau	Management	For	For
1h.	Election of Director: Anne C. Whitaker	Management	For	For
1i.	Election of Director: Kneeland C. Youngblood, M.D.	Management	For	For
2.	Approve, in a non-binding vote, the re-appointment of the Independent Auditors and to authorize, in a binding vote, the Audit Committee to set the auditors’ remuneration.	Management	For	For
3.	Approve, in a non-binding advisory vote, the compensation of named executive officers.	Management	For	For
4.	Approve the authority of the Board to issue shares.	Management	For	For
5.	Authorize the Company and/or any subsidiary to make market purchases or overseas market purchases of Company shares.	Management	For	For
6.	Approve the change of name of the Company. (Special Resolution).	Management	For	For
7.	Approve the waiver of pre-emption rights. (Special Resolution).	Management	For	For
8.	Authorize the price range at which the Company can re- allot shares it holds as treasury shares. (Special Resolution).	Management	For	For
9.	Shareholder Proposal Regarding Incentive Compensation Clawback.	Shareholder	Against	For
10.	Shareholder Proposal Regarding Report on Governance Measures.	Shareholder	Against	For
11.	Shareholder Proposal Regarding Report on Lobbying Activities.	Shareholder	For	For

MASIMO CORPORATION

Security	574795100	Meeting Type	Annual
Ticker Symbol	MASI	Meeting Date	30-May-2019
Record Date	01-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A	Election of Class III Director: Adam Mikkelson	Management	For	For
1B	Election of Class III Director: Craig Reynolds	Management	For	For
2.	To ratify the selection of Grant Thornton as the Company’s independent registered public accounting firm for fiscal year ending December 28, 2019.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Stockholder proposal for proxy access.	Shareholder	Against	For

MEDICAL PROPERTIES TRUST, INC.

Security	58463J304	Meeting Type	Annual
Ticker Symbol	MPW	Meeting Date	23-May-2019
Record Date	21-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Edward K. Aldag, Jr.	Management	For	For
1.2	Election of Director: G. Steven Dawson	Management	For	For
1.3	Election of Director: R. Steven Hamner	Management	For	For
1.4	Election of Director: Elizabeth N. Pitman	Management	For	For
1.5	Election of Director: C. Reynolds Thompson, III	Management	For	For
1.6	Election of Director: D. Paul Sparks, Jr.	Management	For	For
1.7	Election of Director: Michael G. Stewart	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
3.	Non-binding, advisory approval of the Company’s executive compensation.	Management	For	For
4.	To approve the Medical Properties Trust, Inc. 2019 Equity Incentive Plan.	Management	For	For

MEDTRONIC PLC

Security	G5960L103	Meeting Type	Annual
Ticker Symbol	MDT	Meeting Date	07-Dec-2018
Record Date	09-Oct-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Richard H. Anderson	Management	For	For
1b.	Election of Director: Craig Arnold	Management	For	For
1c.	Election of Director: Scott C. Donnelly	Management	For	For
1d.	Election of Director: Randall J. Hogan III	Management	For	For
1e.	Election of Director: Omar Ishrak	Management	For	For
1f.	Election of Director: Michael O. Leavitt	Management	For	For
1g.	Election of Director: James T. Lenehan	Management	For	For
1h.	Election of Director: Elizabeth Nabel, M.D.	Management	For	For
1i.	Election of Director: Denise M. O’Leary	Management	For	For
1j.	Election of Director: Kendall J. Powell	Management	For	For
2.	To ratify, in a non-binding vote, the re-appointment of PricewaterhouseCoopers LLP as Medtronic’s independent auditor for fiscal year 2019 and authorize the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.	Management	For	For
3.	To approve in a non-binding advisory vote, named executive officer compensation (a “Say-on-Pay” vote).	Management	For	For

MERCK & CO., INC.

Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	28-May-2019
Record Date	29-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Leslie A. Brun	Management	For	For
1b.	Election of Director: Thomas R. Cech	Management	For	For
1c.	Election of Director: Mary Ellen Coe	Management	For	For
1d.	Election of Director: Pamela J. Craig	Management	For	For
1e.	Election of Director: Kenneth C. Frazier	Management	For	For
1f.	Election of Director: Thomas H. Glocer	Management	For	For
1g.	Election of Director: Rochelle B. Lazarus	Management	For	For
1h.	Election of Director: Paul B. Rothman	Management	For	For
1i.	Election of Director: Patricia F. Russo	Management	For	For
1j.	Election of Director: Inge G. Thulin	Management	For	For
1k.	Election of Director: Wendell P. Weeks	Management	For	For
1l.	Election of Director: Peter C. Wendell	Management	For	For
2.	Non-binding advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Proposal to adopt the 2019 Incentive Stock Plan.	Management	For	For
4.	Ratification of the appointment of the Company’s independent registered public accounting firm for 2019.	Management	For	For
5.	Shareholder proposal concerning an independent board chairman.	Shareholder	For	Against
6.	Shareholder proposal concerning executive incentives and stock buybacks.	Shareholder	Against	For
7.	Shareholder proposal concerning drug pricing.	Shareholder	Against	For

METTLER-TOLEDO INTERNATIONAL INC.

Security	592688105	Meeting Type	Annual
Ticker Symbol	MTD	Meeting Date	09-May-2019
Record Date	11-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Robert F. Spoerry	Management	For	For
1.2	Election of Director: Wah-Hui Chu	Management	For	For
1.3	Election of Director: Olivier A. Filliol	Management	For	For
1.4	Election of Director: Elisha W. Finney	Management	For	For
1.5	Election of Director: Richard Francis	Management	For	For
1.6	Election of Director: Marco Gadola	Management	For	For
1.7	Election of Director: Michael A. Kelly	Management	For	For
1.8	Election of Director: Thomas P. Salice	Management	For	For
2.	Ratification of Independent Registered Public Account Firm	Management	For	For
3.	Advisory vote to approve Executive Compensation	Management	For	For

MYLAN N.V.

Security	N59465109	Meeting Type	Annual
Ticker Symbol	MYL	Meeting Date	21-Jun-2019
Record Date	24-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Appointment of Director: Heather Bresch	Management	For	For
1B.	Appointment of Director: Hon. Robert J. Cindrich	Management	For	For
1C.	Appointment of Director: Robert J. Coury	Management	For	For
1D.	Appointment of Director: JoEllen Lyons Dillon	Management	For	For
1E.	Appointment of Director: Neil Dimick, C.P.A.	Management	For	For
1F.	Appointment of Director: Melina Higgins	Management	For	For
1G.	Appointment of Director: Harry A. Korman	Management	For	For
1H.	Appointment of Director: Rajiv Malik	Management	For	For
1I.	Appointment of Director: Richard Mark, C.P.A.	Management	For	For
1J.	Appointment of Director: Mark W. Parrish	Management	For	For
1K.	Appointment of Director: Pauline van der Meer Mohr	Management	For	For
1L.	Appointment of Director: Randall L. (Pete) Vanderveen, Ph.D.	Management	For	For
1M.	Appointment of Director: Sjoerd S. Vollebregt	Management	For	For
2.	Approval, on an advisory basis, of the compensation of the named executive officers of the Company	Management	For	For
3.	Adoption of the Dutch annual accounts for fiscal year 2018	Management	For	For
4.	Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2019	Management	For	For
5.	Instruction to Deloitte Accountants B.V. for the audit of the Company’s Dutch statutory annual accounts for fiscal year 2019	Management	For	For
6.	Authorization of the Board to acquire shares in the capital of the Company	Management	For	For
7.	Delegation to the Board of the authority to issue ordinary shares and grant rights to subscribe for ordinary shares in the capital of the Company and to exclude or restrict pre-emptive rights	Management	For	For
8.	SHAREHOLDER VIEW ON DISCUSSION ITEM ONLY - indication of support for amending Company clawback policy similar to that suggested in the shareholder proposal(Agenda Item 10)	Shareholder	Against

NEKTAR THERAPEUTICS

Security	640268108	Meeting Type	Annual
Ticker Symbol	NKTR	Meeting Date	12-Jun-2019
Record Date	15-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: R. Scott Greer	Management	For	For
1b.	Election of Director: Lutz Lingnau	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
3.	To approve a non-binding advisory resolution regarding our executive compensation (a “say-on-pay” vote).	Management	For	For

NEW SENIOR INVESTMENT GROUP INC.

Security	648691103	Meeting Type	Annual
Ticker Symbol	SNR	Meeting Date	12-Jun-2019
Record Date	15-Apr-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Susan Givens		For	For
	2	Michael D. Malone		For	For
	3	David H. Milner		For	For
2.	To ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for New Senior Investment Group Inc. for fiscal year 2019.		Management	For	For
3.	Approval of amendments to our Certificate of Incorporation and Bylaws to provide for the annual election of all directors.		Management	For	For
4.	Approval of amendments to our Certificate of Incorporation and Bylaws to eliminate certain provisions that are no longer applicable.		Management	For	For
5.	Approval of amendments to our Bylaws to implement majority voting in uncontested director elections.		Management	For	For

NOVARTIS AG

Security	66987V109	Meeting Type	Annual
Ticker Symbol	NVS	Meeting Date	28-Feb-2019
Record Date	25-Jan-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis AG and the Group Consolidated Financial Statements for the 2018 Financial Year	Management	For	For
2.	Discharge from Liability of the Members of the Board of Directors and the Executive Committee	Management	For	For
3.	Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend	Management	For	For
4.	Reduction of Share Capital	Management	For	For
5.	Further Share Repurchase Program	Management	For	For
6.	Special Distribution by Way of a Dividend in Kind to Effect the Spin-off of Alcon Inc.	Management	For	For
7a.	Votes on Compensation for the Members of the Board of Directors and the Executive Committee: Binding Vote on the Maximum Aggregate Amount of Compensation for Members of the Board of Directors from the 2019 Annual General Meeting to the 2020 Annual General Meeting	Management	For	For
7b.	Votes on Compensation for the Members of the Board of Directors and the Executive Committee: Binding Vote on the Maximum Aggregate Amount of Compensation for Members of the Executive Committee for the next Financial Year, i.e. 2020	Management	For	For
7c.	Votes on Compensation for the Members of the Board of Directors and the Executive Committee: Advisory Vote on the 2018 Compensation Report	Management	For	For
8a.	Re-election of Joerg Reinhardt, Ph.D., and re-election as Chairman of the Board of Directors (in a single vote)	Management	For	For
8b.	Re-election of Director: Nancy C. Andrews, M.D., Ph.D.	Management	For	For
8c.	Re-election of Director: Ton Buechner	Management	For	For
8d.	Re-election of Director: Srikant Datar, Ph.D.	Management	For	For
8e.	Re-election of Director: Elizabeth Doherty	Management	For	For
8f.	Re-election of Director: Ann Fudge	Management	For	For
8g.	Re-election of Director: Frans van Houten	Management	For	For
8h.	Re-election of Director: Andreas von Planta, Ph.D.	Management	For	For
8i.	Re-election of Director: Charles L. Sawyers, M.D.	Management	For	For
8j.	Re-election of Director: Enrico Vanni, Ph.D.	Management	For	For
8k.	Re-election of Director: William T. Winters	Management	For	For
8l.	Election of Director: Patrice Bula	Management	For	For
9a.	Re-election of Srikant Datar, Ph.D., as member of the Compensation Committee	Management	For	For
9b.	Re-election of Ann Fudge as member of the Compensation Committee	Management	For	For
9c.	Re-election of Enrico Vanni, Ph.D., as member of the Compensation Committee	Management	For	For
9d.	Re-election of William T. Winters as member of the Compensation Committee	Management	For	For
9e.	Election of Patrice Bula as member of the Compensation Committee	Management	For	For
10.	Re-election of the Statutory Auditor	Management	For	For
11.	Re-election of the Independent Proxy	Management	For	For
12.	General instructions in case of alternative motions under the agenda items published in the Notice of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 700 paragraph 3 of the Swiss Code of Obligations.	Management	For	For

NOVAVAX, INC.

Security	670002104	Meeting Type	Special
Ticker Symbol	NVAX	Meeting Date	08-May-2019
Record Date	25-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	An amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio of 1-for-20.	Management	For	For

NOVAVAX, INC.

Security	670002104	Meeting Type	Annual
Ticker Symbol		Meeting Date	28-Jun-2019
Record Date	02-May-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Rachel K. King		For	For
	2	Michael A. McManus, Jr.		For	For
	3	James F. Young		For	For
2.	To consider and vote whether to approve, on an advisory basis, the compensation paid to our Named Executive Officers.		Management	For	For
3.	To amend and restate the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of the Company’s common stock, par value $0.01, available for issuance thereunder by 1,000,000 shares.		Management	For	For
4.	To amend and restate the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares of the Company’s common stock, par value $0.01 available for issuance thereunder by 200,000 shares.		Management	For	For
5.	To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.		Management	For	For

OCULIS SA

Security	N/A	Meeting Type	Annual
Ticker Symbol	N/A	Meeting Date	28-Jun-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approval of Annual Report including Financial Statements	Management	For	For
2	Appropriation of Balance Sheet Results 2018	Management	For	For
3	Discharge of the Members of the Board and Management	Management	For	For
4	Re-Election / Election of the board of Directors	Management	For	For
5	Election of the Auditors	Management	For	For

OMEGA HEALTHCARE INVESTORS, INC.

Security	681936100	Meeting Type	Annual
Ticker Symbol	OHI	Meeting Date	07-Jun-2019
Record Date	15-Apr-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Kapila K. Anand		For	For
	2	Norman R. Bobins		For	For
	3	Craig R. Callen		For	For
	4	Barbara B. Hill		For	For
	5	Edward Lowenthal		For	For
	6	C. Taylor Pickett		For	For
	7	Stephen D. Plavin		For	For
	8	Burke W. Whitman		For	For
2.	Ratification of Independent Auditors Ernst & Young LLP.		Management	For	For
3.	Approval, on an Advisory Basis, of Executive Compensation.		Management	For	For
4.	Approval of Employee Stock Purchase Plan.		Management	For	For

OTSUKA HOLDINGS CO.,LTD.

Security	J63117105	Meeting Type	Annual General Meeting
Ticker Symbol	OTSKF	Meeting Date	28-Mar-2019
Record Date	31-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Otsuka, Ichiro	Management	For	For
1.2	Appoint a Director Higuchi, Tatsuo	Management	For	For
1.3	Appoint a Director Matsuo, Yoshiro	Management	For	For
1.4	Appoint a Director Makino, Yuko	Management	For	For
1.5	Appoint a Director Tobe, Sadanobu	Management	For	For
1.6	Appoint a Director Makise, Atsumasa	Management	For	For
1.7	Appoint a Director Kobayashi, Masayuki	Management	For	For
1.8	Appoint a Director Tojo, Noriko	Management	For	For
1.9	Appoint a Director Takagi, Shuichi	Management	For	For
1.10	Appoint a Director Matsutani, Yukio	Management	For	For
1.11	Appoint a Director Sekiguchi, Ko	Management	For	For
1.12	Appoint a Director Aoki, Yoshihisa	Management	For	For
2	Approve Details of the Restricted-Share Compensation to be received by Directors	Management	For	For

PERRIGO COMPANY PLC

Security	G97822103	Meeting Type	Annual
Ticker Symbol	PRGO	Meeting Date	26-Apr-2019
Record Date	26-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Bradley A. Alford	Management	For	For
1b.	Election of Director: Rolf A. Classon	Management	For	For
1c.	Election of Director: Adriana Karaboutis	Management	For	For
1d.	Election of Director: Murray S. Kessler	Management	For	For
1e.	Election of Director: Jeffrey B. Kindler	Management	For	For
1f.	Election of Director: Erica L. Mann	Management	For	For
1g.	Election of Director: Donal O’Connor	Management	For	For
1h.	Election of Director: Geoffrey M. Parker	Management	For	For
1i.	Election of Director: Theodore R. Samuels	Management	For	For
1j.	Election of Director: Jeffrey C. Smith	Management	For	For
2.	Ratify the appointment of Ernst & Young LLP as our independent auditor for the period ending December 31, 2019, and authorize the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor.	Management	For	For
3.	Advisory vote on the Company’s executive compensation.	Management	For	For
4.	Renew and restate the Company’s Long-Term Incentive Plan.	Management	For	For
5.	Approve the creation of distributable reserves by reducing some or all of the Company’s share premium.	Management	For	For
6.	Renew the Board’s authority to issue shares under Irish law.	Management	For	For
7.	Renew the Board’s authority to opt-out of statutory pre- emption rights under Irish law.	Management	For	For

PFIZER INC.

Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	25-Apr-2019
Record Date	26-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Ronald E. Blaylock	Management	For	For
1b.	Election of Director: Albert Bourla	Management	For	For
1c.	Election of Director: W. Don Cornwell	Management	For	For
1d.	Election of Director: Joseph J. Echevarria	Management	For	For
1e.	Election of Director: Helen H. Hobbs	Management	For	For
1f.	Election of Director: James M. Kilts	Management	For	For
1g.	Election of Director: Dan R. Littman	Management	For	For
1h.	Election of Director: Shantanu Narayen	Management	For	For
1i.	Election of Director: Suzanne Nora Johnson	Management	For	For
1j.	Election of Director: Ian C. Read	Management	For	For
1k.	Election of Director: James C. Smith	Management	For	For
2.	Ratify the selection of KPMG LLP as independent registered public accounting firm for 2019	Management	For	For
3.	2019 Advisory approval of executive compensation	Management	For	For
4.	Approval of the Pfizer Inc. 2019 Stock Plan	Management	For	For
5.	Shareholder proposal regarding right to act by written consent	Shareholder	Against	For
6.	Shareholder proposal regarding report on lobbying activities	Shareholder	Against	For
7.	Shareholder proposal regarding independent chair policy	Shareholder	For	Against
8.	Shareholder proposal regarding integrating drug pricing into executive compensation policies and programs	Shareholder	Against	For

PHYSICIANS REALTY TRUST

Security	71943U104	Meeting Type	Annual
Ticker Symbol	DOC	Meeting Date	30-Apr-2019
Record Date	25-Feb-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	John T. Thomas		For	For
	2	Tommy G. Thompson		For	For
	3	Stanton D. Anderson		For	For
	4	Mark A. Baumgartner		For	For
	5	Albert C. Black, Jr.		For	For
	6	William A Ebinger M.D		For	For
	7	Pamela J. Kessler		For	For
	8	Richard A. Weiss		For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.		Management	For	For
3.	To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.		Management	For	For
4.	To approve the Amended and Restated Physicians Realty Trust 2013 Equity Incentive Plan.		Management	For	For

QUEST DIAGNOSTICS INCORPORATED

Security	74834L100	Meeting Type	Annual
Ticker Symbol	DGX	Meeting Date	14-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Vicky B. Gregg	Management	For	For
1.2	Election of Director: Timothy L. Main	Management	For	For
1.3	Election of Director: Denise M. Morrison	Management	For	For
1.4	Election of Director: Gary M. Pfeiffer	Management	For	For
1.5	Election of Director: Timothy M. Ring	Management	For	For
1.6	Election of Director: Stephen H. Rusckowski	Management	For	For
1.7	Election of Director: Daniel C. Stanzione	Management	For	For
1.8	Election of Director: Helen I. Torley	Management	For	For
1.9	Election of Director: Gail R. Wilensky	Management	For	For
2.	An advisory resolution to approve the executive officer compensation disclosed in the Company’s 2019 proxy statement	Management	For	For
3.	Ratification of the appointment of our independent registered public accounting firm for 2019	Management	For	For
4.	Approval of an amendment to the Amended and Restated Employee Long-Term Incentive Plan	Management	For	For

QUORUM HEALTH CORPORATION

Security	74909E106	Meeting Type	Annual
Ticker Symbol	QHC	Meeting Date	31-May-2019
Record Date	01-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Terry Allison Rappuhn	Management	For	For
1.2	Election of Director: Robert H. Fish	Management	For	For
1.3	Election of Director: Joseph A. Hastings, D.M.D.	Management	For	For
1.4	Election of Director: Jon H. Kaplan	Management	For	For
1.5	Election of Director: Barbara R. Paul, M.D.	Management	For	For
1.6	Election of Director: William Paul Rutledge	Management	For	For
1.7	Election of Director: Alice D. Schroeder	Management	For	For
1.8	Election of Director: R. Lawrence Van Horn, Ph.D.	Management	For	For
2.	To approve the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan.	Management	For	For
3.	To approve the Quorum Health Corporation 2018 Restricted Stock Plan.	Management	For	For
4.	To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers, as more fully described in the accompanying proxy statement (“say-on-pay”).	Management	For	For
5.	To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the year ending December 31, 2019.	Management	For	For

RAINIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	30-Jan-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Authorization and Approval of Note Financing	Management	For	For
2	Waiver of Anti-Dilution Rights	Management	For	For
3	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	23-Apr-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment of Certificate of Incorporation	Management	For	For
2	Amendment and Restatement of 2013 Stock Option and Grant Plan	Management	For	For
3	General Authorizing Resolution	Management	For	For

REGENERON PHARMACEUTICALS, INC.

Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	14-Jun-2019
Record Date	17-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Bonnie L. Bassler, Ph.D.	Management	For	For
1b.	Election of Director: Michael S. Brown, M.D.	Management	For	For
1c.	Election of Director: Leonard S. Schleifer, M.D., Ph.D.	Management	For	For
1d.	Election of Director: George D. Yancopoulos, M.D., Ph.D.	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For

RESMED INC.

Security	761152107	Meeting Type	Annual
Ticker Symbol	RMD	Meeting Date	15-Nov-2018
Record Date	17-Sep-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of director to serve until our 2021 annual meeting: Peter Farrell	Management	For	For
1b.	Election of director to serve until our 2021 annual meeting: Harjit Gill	Management	For	For
1c.	Election of director to serve until our 2021 annual meeting: Ron Taylor	Management	For	For
2.	Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2019.	Management	For	For
3.	Approve an amendment to the ResMed Inc. 2009 Employee Stock Purchase Plan, which increases the number of shares authorized for issue under the plan by 2 million shares, from 4.2 million shares to 6.2 million shares, and extends the term of the plan through November 15, 2028.	Management	For	For
4.	Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in this proxy statement (“say-on-pay”).	Management	For	For

SABRA HEALTH CARE REIT, INC.

Security	78573L106	Meeting Type	Annual
Ticker Symbol	SBRA	Meeting Date	21-Jun-2019
Record Date	24-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Craig A. Barbarosh	Management	For	For
1b.	Election of Director: Robert A. Ettl	Management	For	For
1c.	Election of Director: Michael J. Foster	Management	For	For
1d.	Election of Director: Ronald G. Geary	Management	For	For
1e.	Election of Director: Lynne S. Katzmann	Management	For	For
1f.	Election of Director: Raymond J. Lewis	Management	For	For
1g.	Election of Director: Jeffrey A. Malehorn	Management	For	For
1h.	Election of Director: Richard K. Matros	Management	For	For
1l.	Election of Director: Milton J. Walters	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of Sabra’s named executive officers.	Management	For	For

SANOFI

Security	80105N105	Meeting Type	Annual
Ticker Symbol	SNY	Meeting Date	30-Apr-2019
Record Date	27-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the individual company financial statements for the year ended December 31, 2018	Management	For	For
2.	Approval of the consolidated financial statements for the year ended December 31, 2018	Management	For	For
3.	Appropriation of profits for the year ended December 31, 2018 and declaration of dividend	Management	For	For
4.	Reappointment of Serge Weinberg as a Director	Management	For	For
5.	Reappointment of Suet-Fern Lee as a Director	Management	For	For
6.	Ratification of the Board’s appointment by cooptation of Christophe Babule as Director	Management	For	For
7.	Compensation policy for the Chairman of the Board of Directors	Management	For	For
8.	Compensation policy for the Chief Executive Officer	Management	For	For
9.	Approval of the payment, in respect of the year ended December 31, 2018, and of the award, of the fixed, variable and ..(Due to space limits, see proxy material for full proposal)	Management	For	For
10.	Approval of the payment, in respect of the year ended December 31, 2018, and of the award, of the fixed, variable and ..(Due to space limits, see proxy material for full proposal)	Management	For	For
11.	Authorization granted to the Board of Directors to carry out transactions in the Company’s shares (usable outside the period of a public tender offer)	Management	For	For
12.	Authorization to the Board of Directors to reduce the share capital by cancellation of treasury shares (usable outside the period of a public tender offer)	Management	For	For
13.	Delegation to the Board of Directors of authority to decide to issue, with preemptive rights maintained, shares and/or ..(Due to space limits, see proxy material for full proposal)	Management	For	For
14.	Delegation to the Board of Directors of authority to decide to issue, with preemptive rights cancelled, shares and/or ..(Due to space limits, see proxy material for full proposal)	Management	For	For
15.	Delegation to the Board of Directors of authority to decide to issue, with preemptive rights cancelled, shares and/or ..(Due to space limits, see proxy material for full proposal)	Management	For	For
16.	Delegation to the Board of Directors of authority to decide to issue debt instruments giving access to the share capital of ..(Due to space limits, see proxy material for full proposal)	Management	For	For
17.	Delegation to the Board of Directors of authority to increase the number of shares to be issued in the event of an issue of ..(Due to space limits, see proxy material for full proposal)	Management	For	For
18.	Delegation to the Board of Directors of authority with a view to the issuance, with preemptive rights cancelled, of shares ..(Due to space limits, see proxy material for full proposal)	Management	For	For
19.	Delegation to the Board of Directors of authority to grant, without preemptive right, options to subscribe for or purchase shares	Management	For	For
20.	Authorization for the Board of Directors to carry out consideration-free allotments of existing or new shares to some or all of the salaried employees and corporate officers of the Group	Management	For	For
21.	Delegation to the Board of Directors of authority to decide to carry out increases in the share capital by incorporation of share premium, reserves, profits or other items (usable outside the period of a public tender offer)	Management	For	For
22.	Delegation to the Board of Directors of authority to decide on the issuance of shares or securities giving access to the Company’s share capital reserved for members of savings plans, with waiver of preemptive rights in their favor	Management	For	For
23.	Powers for formalities	Management	For	For

SENIOR HOUSING PROPERTIES TRUST

Security	81721M109	Meeting Type	Annual
Ticker Symbol	SNH	Meeting Date	21-May-2019
Record Date	28-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Trustee: John L. Harrington (for Independent Trustee in Class II)	Management	For	For
1.2	Election of Trustee: Adam D. Portnoy (for Managing Trustee in Class II)	Management	For	For
2.	Advisory vote to approve executive compensation.	Management	For	For
3.	Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2019 fiscal year.	Management	For	For

SHIONOGI & CO.,LTD.

Security	J74229105	Meeting Type	Annual General Meeting
Ticker Symbol	SGIOF	Meeting Date	18-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Shiono, Motozo	Management	For	For
2.2	Appoint a Director Teshirogi, Isao	Management	For	For
2.3	Appoint a Director Sawada, Takuko	Management	For	For
2.4	Appoint a Director Mogi, Teppei	Management	For	For
2.5	Appoint a Director Ando, Keiichi	Management	For	For
2.6	Appoint a Director Ozaki, Hiroshi	Management	For	For
3.1	Appoint a Corporate Auditor Okamoto, Akira	Management	For	For
3.2	Appoint a Corporate Auditor Fujinuma, Tsuguoki	Management	For	For
4	Approve Details of the Compensation to be received by Corporate Auditors	Management	For	For

SHIRE PLC

Security	82481R106	Meeting Type	Special
Ticker Symbol	SHPG	Meeting Date	05-Dec-2018
Record Date	07-Nov-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To approve the Scheme of Arrangement.	Management	For	For
2.	Special Resolution: THAT for the purpose of giving effect to the Scheme of Arrangement: (1) the Board of Directors of the Company (the “Board”) be authorized to take all such action as they may consider necessary or appropriate for carrying the Scheme of Arrangement into effect, (2) the articles of association of the Company be amended by the adoption and inclusion of a new Article 154 and (3) conditional upon and with effect from the sanctioning of the Scheme of Arrangement ...(due to space limits, see proxy material for full proposal).	Management	For	For

SMITH & NEPHEW PLC

Security	83175M205	Meeting Type	Annual
Ticker Symbol	SNN	Meeting Date	11-Apr-2019
Record Date	22-Feb-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To receive the audited accounts.	Management	For	For
O2	To approve the Directors’ Remuneration Report (excluding policy)	Management	For	For
O3	To declare a final dividend.	Management	For	For
O4	Election/Re-Election of Director: Graham Baker	Management	For	For
O5	Election/Re-Election of Director: Vinita Bali	Management	For	For
O6	Election/Re-Election of Director: The Rt. Hon Baroness Virginia Bottomley	Management	For	For
O7	Election/Re-Election of Director: Roland Diggelmann	Management	For	For
O8	Election/Re-Election of Director: Erik Engstrom	Management	For	For
O9	Election/Re-Election of Director: Robin Freestone	Management	For	For
O10	Election/Re-Election of Director: Namal Nawana	Management	For	For
O11	Election/Re-Election of Director: Marc Owen	Management	For	For
O12	Election/Re-Election of Director: Angie Risley	Management	For	For
O13	Election/Re-Election of Director: Roberto Quarta	Management	For	For
O14	To re-appoint the Auditor.	Management	For	For
O15	To authorise the Directors to determine the remuneration of the Auditor.	Management	For	For
O16	To renew the Directors’ authority to allot shares.	Management	For	For
S17	To renew the Directors’ authority for the disapplication of the pre-emption rights.	Management	For	For
S18	To renew the Directors’ limited authority to make market purchases of the Company’s own shares.	Management	For	For
S19	To authorise general meetings to be held on 14 clear days’ notice.	Management	For	For
S20	To adopt new Articles of Association.	Management	For	For

SOSEI GROUP CORPORATION

Security	J7637L109	Meeting Type	Annual General Meeting
Ticker Symbol	SOLTF	Meeting Date	27-Mar-2019
Record Date	31-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Tamura, Shinichi	Management	For	For
1.2	Appoint a Director Toyama, Tomohiro	Management	For	For
1.3	Appoint a Director Julia Gregory	Management	For	For
1.4	Appoint a Director Kaga, Kuniaki	Management	For	For
1.5	Appoint a Director David Roblin	Management	For	For
1.6	Appoint a Director Nagai, Noriaki	Management	For	For

STERIS PLC

Security	G84720104	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	28-Feb-2019
Record Date	25-Jan-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Special resolution to approve the Scheme, a reduction of the share capital of STERIS plc and certain ancillary matters, as set forth in STERIS plc’s Proxy Statement/Prospectus, dated January 31, 2019.	Management	For	For
2.	Special resolution to approve the creation of distributable profits within STERIS Ireland.	Management	For	For

STRYKER CORPORATION

Security	863667101	Meeting Type	Annual
Ticker Symbol	SYK	Meeting Date	01-May-2019
Record Date	04-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a)	Election of Director: Mary K. Brainerd	Management	For	For
1b)	Election of Director: Srikant M. Datar, Ph.D.	Management	For	For
1c)	Election of Director: Roch Doliveux, DVM	Management	For	For
1d)	Election of Director: Louise L. Francesconi	Management	For	For
1e)	Election of Director: Allan C. Golston (Lead Independent Director)	Management	For	For
1f)	Election of Director: Kevin A. Lobo (Chairman of the Board)	Management	For	For
1g)	Election of Director: Sherilyn S. McCoy	Management	For	For
1h)	Election of Director: Andrew K. Silvernail	Management	For	For
1i)	Election of Director: Ronda E. Stryker	Management	For	For
1j)	Election of Director: Rajeev Suri	Management	For	For
2.	Ratify appointment of Ernst & Young LLP as our independent registered public accounting firm for 2019.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Security	J8129E108	Meeting Type	Annual General Meeting
Ticker Symbol	TKPHF	Meeting Date	27-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Christophe Weber	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Iwasaki, Masato	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Andrew Plump	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Constantine Saroukos	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Sakane, Masahiro	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Olivier Bohuon	Management	For	For
2.7	Appoint a Director who is not Audit and Supervisory Committee Member Ian Clark	Management	For	For
2.8	Appoint a Director who is not Audit and Supervisory Committee Member Fujimori, Yoshiaki	Management	For	For
2.9	Appoint a Director who is not Audit and Supervisory Committee Member Steven Gillis	Management	For	For
2.10	Appoint a Director who is not Audit and Supervisory Committee Member Shiga, Toshiyuki	Management	For	For
2.11	Appoint a Director who is not Audit and Supervisory Committee Member Jean-Luc Butel	Management	For	For
2.12	Appoint a Director who is not Audit and Supervisory Committee Member Kuniya, Shiro	Management	For	For
3.1	Appoint a Director who is Audit and Supervisory Committee Member Higashi, Emiko	Management	For	For
3.2	Appoint a Director who is Audit and Supervisory Committee Member Michel Orsinger	Management	For	For
4	Approve Details of the Stock Compensation to be received by Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For
5	Approve Details of the Stock Compensation to be received by Directors who are Audit and Supervisory Committee Members	Management	For	For
6	Approve Payment of Bonuses to Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For
7	Shareholder Proposal: Amend Articles of Incorporation (Individual disclosure of the directors’ compensation)	Shareholder	Against	For
8	Shareholder Proposal: Amend Articles of Incorporation (Adoption of a clawback clause)	Shareholder	Against	For

TERUMO CORPORATION

Security	J83173104	Meeting Type	Annual General Meeting
Ticker Symbol	TRUMPF	Meeting Date	21-Jun-2019
Record Date	31-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Mimura, Takayoshi	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Sato, Shinjiro	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Takagi, Toshiaki	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Hatano, Shoji	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Nishikawa, Kyo	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Mori, Ikuo	Management	For	For
2.7	Appoint a Director who is not Audit and Supervisory Committee Member Ueda, Ryuzo	Management	For	For
2.8	Appoint a Director who is not Audit and Supervisory Committee Member Kuroda, Yukiko	Management	For	For
3.1	Appoint a Director who is Audit and Supervisory Committee Member Kimura, Yoshihiro	Management	For	For
3.2	Appoint a Director who is Audit and Supervisory Committee Member Nakamura, Masaichi	Management	For	For
3.3	Appoint a Director who is Audit and Supervisory Committee Member Uno, Soichiro	Management	For	For
4	Appoint a Substitute Director who is Audit and Supervisory Committee Member Sakaguchi, Koichi	Management	For	For
5	Approve Details of the Restricted-Share Compensation to be received by Directors (Excluding Directors who are Audit and Supervisory Committee Members and Outside Directors)	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	11-Jun-2019
Record Date	02-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Amir Elstein	Management	For	For
1b.	Election of Director: Roberto A. Mignone	Management	For	For
1c.	Election of Director: Dr. Perry D. Nisen	Management	For	For
2.	To Approve, on a Non-Binding Advisory Basis, the Compensation for Teva’s Named Executive Officers.	Management	For	For
3.	To Approve an Amended Compensation Policy with respect to the Terms of Office and Employment of Teva’s Executive Officers and Directors.	Management	For	For
3a.	Regarding proposal 3, please indicate when you vote whether or not you are a “controlling shareholder” of Teva and whether or not you have a personal benefit or other interest in this proposal IMPORTANT NOTE: if you do not complete this section, or if you indicate that you are a controlling shareholder or that you have a personal benefit or other interest in the proposal, your vote on proposal 3 will not be counted for purposes of the Disinterested Majority. MARK ‘FOR’ = YES OR ‘AGAINST’ = NO.	Management	Against
4a.	Director Compensation: To Approve the Compensation to be Provided to Teva’s Non-Employee Directors.	Management	For	For
4b.	Director Compensation: To Approve the Compensation to be Provided to Teva’s Non-Executive Chairman of the Board.	Management	For	For
5.	To Appoint Kesselman & Kesselman, a Member of PricewaterhouseCoopers International Ltd., as Teva’s Independent Registered Public Accounting Firm until Teva’s 2020 Annual Meeting of Shareholders.	Management	For	For

THE MEDICINES COMPANY

Security	584688105	Meeting Type	Annual
Ticker Symbol	MDCO	Meeting Date	30-May-2019
Record Date	11-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Alexander J. Denner	Management	For	For
1B.	Election of Director: Geno J. Germano	Management	For	For
1C.	Election of Director: John C. Kelly	Management	For	For
1D.	Election of Director: Clive A. Meanwell	Management	For	For
1E.	Election of Director: Paris Panayiotopoulos	Management	For	For
1F.	Election of Director: Sarah J. Schlesinger	Management	For	For
1G.	Election of Director: Mark Timney	Management	For	For
2.	Approve, in an advisory vote, the compensation of our named executive officers as presented in the proxy statement.	Management	For	For
3.	Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For

THERMO FISHER SCIENTIFIC INC.

Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	22-May-2019
Record Date	27-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Marc N. Casper	Management	For	For
1b.	Election of Director: Nelson J. Chai	Management	For	For
1c.	Election of Director: C. Martin Harris	Management	For	For
1d.	Election of Director: Tyler Jacks	Management	For	For
1e.	Election of Director: Judy C. Lewent	Management	For	For
1f.	Election of Director: Thomas J. Lynch	Management	For	For
1g.	Election of Director: Jim P. Manzi	Management	For	For
1h.	Election of Director: James C. Mullen	Management	For	For
1i.	Election of Director: Lars R. Sørensen	Management	For	For
1j.	Election of Director: Scott M. Sperling	Management	For	For
1k.	Election of Director: Elaine S. Ullian	Management	For	For
1l.	Election of Director: Dion J. Weisler	Management	For	For
2.	An advisory vote to approve named executive officer compensation.	Management	For	For
3.	Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent auditors for 2019.	Management	For	For

UNITEDHEALTH GROUP INCORPORATED

Security	91324P102	Meeting Type	Annual
Ticker Symbol	UNH	Meeting Date	03-Jun-2019
Record Date	09-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: William C. Ballard, Jr.	Management	For	For
1b.	Election of Director: Richard T. Burke	Management	For	For
1c.	Election of Director: Timothy P. Flynn	Management	For	For
1d.	Election of Director: Stephen J. Hemsley	Management	For	For
1e.	Election of Director: Michele J. Hooper	Management	For	For
1f.	Election of Director: F. William McNabb III	Management	For	For
1g.	Election of Director: Valerie C. Montgomery Rice, M.D.	Management	For	For
1h.	Election of Director: John H. Noseworthy, M.D.	Management	For	For
1i.	Election of Director: Glenn M. Renwick	Management	For	For
1j.	Election of Director: David S. Wichmann	Management	For	For
1k.	Election of Director: Gail R. Wilensky, Ph.D.	Management	For	For
2.	Advisory approval of the Company’s executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2019.	Management	For	For
4.	The shareholder proposal set forth in the proxy statement requesting an amendment to the proxy access bylaw, if properly presented at the 2019 Annual Meeting of Shareholders.	Shareholder	Against	For

VARIAN MEDICAL SYSTEMS, INC.

Security	92220P105	Meeting Type	Annual
Ticker Symbol	VAR	Meeting Date	14-Feb-2019
Record Date	17-Dec-2018

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Anat Ashkenazi	Management	For	For
1b.	Election of Director: Jeffrey R. Balser	Management	For	For
1c.	Election of Director: Judy Bruner	Management	For	For
1d.	Election of Director: Jean-Luc Butel	Management	For	For
1e.	Election of Director: Regina E. Dugan	Management	For	For
1f.	Election of Director: R. Andrew Eckert	Management	For	For
1g.	Election of Director: Timothy E. Guertin	Management	For	For
1h.	Election of Director: David J. Illingworth	Management	For	For
1i.	Election of Director: Dow R. Wilson	Management	For	For
2.	To approve, on an advisory basis, the compensation of the Varian Medical Systems, Inc. named executive officers as described in the Proxy Statement.	Management	For	For
3.	To ratify the appointment of PricewaterhouseCoopers LLP as Varian Medical Systems, Inc.’s independent registered public accounting firm for fiscal year 2019.	Management	For	For

VENTAS, INC.

Security	92276F100	Meeting Type	Annual
Ticker Symbol	VTR	Meeting Date	14-May-2019
Record Date	15-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Melody C. Barnes	Management	For	For
1B.	Election of Director: Debra A. Cafaro	Management	For	For
1C.	Election of Director: Jay M. Gellert	Management	For	For
1D.	Election of Director: Richard I. Gilchrist	Management	For	For
1E.	Election of Director: Matthew J. Lustig	Management	For	For
1F.	Election of Director: Roxanne M. Martino	Management	For	For
1G.	Election of Director: Walter C. Rakowich	Management	For	For
1H.	Election of Director: Robert D. Reed	Management	For	For
1I.	Election of Director: James D. Shelton	Management	For	For
2.	Ratification of the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2019.	Management	For	For
3.	Advisory vote to approve our executive compensation.	Management	For	For

VERONA PHARMA PLC

Security	925050106	Meeting Type	Annual
Ticker Symbol	VRNA	Meeting Date	07-May-2019
Record Date	19-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To receive and adopt the report of the directors and the financial statements for the year ended 31 December 2018.	Management	For	For
O2	To approve the Directors’ Remuneration Report.	Management	For	For
O3	To re-elect Dr. Ken Cunningham as a director of the Company.	Management	For	For
O4	To re-elect Dr. Andrew Sinclair as a director of the Company.	Management	For	For
O5	To re-elect Dr. Martin Edwards as a director of the Company.	Management	For	For
O6	To appoint PricewaterhouseCoopers LLP as auditors.	Management	For	For
O7	To authorise the directors to determine the auditors remuneration.	Management	For	For
O8	To authorise the directors to allot relevant securities pursuant to Section 551 of the Companies Act 2006.	Management	For	For
S9	To authorise the directors to allot equity securities pursuant to Section 570 of the Companies Act 2006.	Management	For	For

VERTEX PHARMACEUTICALS INCORPORATED

Security	92532F100	Meeting Type	Annual
Ticker Symbol	VRTX	Meeting Date	05-Jun-2019
Record Date	10-Apr-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Sangeeta Bhatia	Management	For	For
1.2	Election of Director: Lloyd Carney	Management	For	For
1.3	Election of Director: Terrence Kearney	Management	For	For
1.4	Election of Director: Yuchun Lee	Management	For	For
1.5	Election of Director: Jeffrey Leiden	Management	For	For
1.6	Election of Director: Bruce Sachs	Management	For	For
2.	Amendment and restatement of our 2013 Stock and Option Plan to, among other things, increase the number of shares available under the plan by 5.0 million shares.	Management	For	For
3.	Amendment and restatement of our 2013 Employee Stock Purchase Plan to, among other things, increase the number of shares available under the plan by 2.0 million shares.	Management	For	For
4.	Ratification of Ernst & Young LLP as our Independent Registered Public Accounting firm for the year ending December 31, 2019.	Management	For	For
5.	Advisory vote on named executive officer compensation.	Management	For	For
6.	Shareholder proposal, if properly presented at the meeting, requesting annual reporting on the integration of risks relating to drug prices into our executive compensation program.	Shareholder	Against	For
7.	Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on our policies and activities with respect to lobbying.	Shareholder	Against	For

WELLCARE HEALTH PLANS, INC.

Security	94946T106	Meeting Type	Annual
Ticker Symbol	WCG	Meeting Date	22-May-2019
Record Date	25-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Richard C. Breon	Management	For	For
1b.	Election of Director: Kenneth A. Burdick	Management	For	For
1c.	Election of Director: Amy L. Compton-Phillips	Management	For	For
1d.	Election of Director: H. James Dallas	Management	For	For
1e.	Election of Director: Kevin F. Hickey	Management	For	For
1f.	Election of Director: Christian P. Michalik	Management	For	For
1g.	Election of Director: Piyush “Bobby” Jindal	Management	For	For
1h.	Election of Director: William L. Trubeck	Management	For	For
1i.	Election of Director: Kathleen E. Walsh	Management	For	For
2.	Approval of the Company’s 2019 Incentive Compensation Plan.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.	Management	For	For
4.	Advisory vote on the compensation of the Company’s named executive officers (“Say on Pay”).	Management	For	For

WELLCARE HEALTH PLANS, INC.

Security	94946T106	Meeting Type	Special
Ticker Symbol	WCG	Meeting Date	24-Jun-2019
Record Date	22-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To adopt the Agreement and Plan of Merger, dated as of March 26, 2019 (the “Merger Agreement”), by and among Centene Corporation, Wellington Merger Sub I, Inc., Wellington Merger Sub II, Inc. and WellCare Health Plans, Inc. (“WellCare”), as may be amended from time to time (the “Merger Agreement Proposal”).	Management	For	For
2.	To approve, on a non-binding advisory basis, compensation payable to executive officers of WellCare in connection with the transactions contemplated by the Merger Agreement.	Management	For	For
3.	To approve any proposal to adjourn the special meeting of stockholders of WellCare (the “WellCare Special Meeting”) from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the WellCare Special Meeting to approve the Merger Agreement Proposal.	Management	For	For

WELLTOWER INC.

Security	95040Q104	Meeting Type	Annual
Ticker Symbol	WELL	Meeting Date	02-May-2019
Record Date	05-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kenneth J. Bacon	Management	For	For
1b.	Election of Director: Thomas J. DeRosa	Management	For	For
1c.	Election of Director: Karen B. DeSalvo	Management	For	For
1d.	Election of Director: Jeffrey H. Donahue	Management	For	For
1e.	Election of Director: Timothy J. Naughton	Management	For	For
1f.	Election of Director: Sharon M. Oster	Management	For	For
1g.	Election of Director: Sergio D. Rivera	Management	For	For
1h.	Election of Director: Johnese M. Spisso	Management	For	For
1i.	Election of Director: Kathryn M. Sullivan	Management	For	For
1j.	Election of Director: R. Scott Trumbull	Management	For	For
1k.	Election of Director: Gary Whitelaw	Management	For	For
2.	The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2019.	Management	For	For
3.	The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2019 Proxy Statement.	Management	For	For

WRIGHT MEDICAL GROUP N V

Security	N96617118	Meeting Type	Annual
Ticker Symbol	WMGI	Meeting Date	28-Jun-2019
Record Date	01-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Appointment of Robert J. Palmisano for executive director. Mark “For” to appoint Palmisano.	Management	For	For
1b.	Appointment of David D. Stevens for non-executive director. Mark “For” to appoint Stevens.	Management	For	For
1c.	Appointment of Gary D. Blackford for non-executive director. Mark “For” to appoint Blackford.	Management	For	For
1d.	Appointment of J. Patrick Mackin for non-executive director. Mark “For” to appoint Mackin.	Management	For	For
1e.	Appointment of John L. Miclot for non-executive director. Mark “For” to appoint Miclot.	Management	For	For
1f.	Appointment of Kevin C. O’Boyle for non-executive director. Mark “For” to appoint O’Boyle.	Management	For	For
1g.	Appointment of Amy S. Paul for non-executive director. Mark “For” to appoint Paul.	Management	For	For
1h.	Appointment of Richard F. Wallman for non-executive director. Mark “For” to appoint Wallman.	Management	For	For
1i.	Appointment of Elizabeth H. Weatherman for non- executive director. Mark “For” to appoint Weatherman.	Management	For	For
2.	Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2019.	Management	For	For
3.	Appointment of KPMG N.V. as the auditor for our Dutch statutory annual accounts for the fiscal year ending December 29, 2019.	Management	For	For
4.	Adoption of our Dutch statutory annual accounts for the fiscal year ended December 30, 2018.	Management	For	For
5.	Release of each member of our board of directors from liability with respect to the exercise of his or her duties during the fiscal year ended December 30, 2018.	Management	For	For
6.	Extension of the authority of our board of directors to repurchase up to 10% of our issued share capital (including depositary receipts issued for our shares) until December 28, 2020 on the open market, through privately negotiated transactions or in one or more self- tender offers for a price per share (or depositary receipt) not less than the nominal value of a share and not higher than 110% of the market price of a share (or depositary receipt) at the time of the transaction.	Management	For	For
7.	Limited authorization of our board of directors to issue ordinary shares or grant rights to subscribe for ordinary shares up to 20% of our issued and outstanding shares at the time of the issue until June 28, 2021.	Management	For	For
8.	Limited authorization of our board of directors to resolve to exclude or restrict our shareholders’ pre-emptive rights under Dutch law with respect to the ordinary shares and rights to subscribe therefor that the board of directors may issue or grant pursuant to the authority in proposal 7 above until June 28, 2021.	Management	For	For
9.	Approval of the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.	Management	For	For
10.	Approval, on an advisory basis, of our executive compensation.	Management	For	For

ZIMMER BIOMET HOLDINGS, INC.

Security	98956P102	Meeting Type	Annual
Ticker Symbol	ZBH	Meeting Date	10-May-2019
Record Date	11-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Christopher B. Begley	Management	For	For
1b.	Election of Director: Betsy J. Bernard	Management	For	For
1c.	Election of Director: Gail K. Boudreaux	Management	For	For
1d.	Election of Director: Michael J. Farrell	Management	For	For
1e.	Election of Director: Larry C. Glasscock	Management	For	For
1f.	Election of Director: Robert A. Hagemann	Management	For	For
1g.	Election of Director: Bryan C. Hanson	Management	For	For
1h.	Election of Director: Arthur J. Higgins	Management	For	For
1i.	Election of Director: Maria Teresa Hilado	Management	For	For
1j.	Election of Director: Syed Jafry	Management	For	For
1K.	Election of Director: Michael W. Michelson	Management	For	For
2.	Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2019	Management	For	For
3.	Advisory vote to approve named executive officer compensation (Say on Pay)	Management	For	For

ZOETIS INC.

Security	98978V103	Meeting Type	Annual
Ticker Symbol	ZTS	Meeting Date	15-May-2019
Record Date	21-Mar-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Juan Ramon Alaix	Management	For	For
1.2	Election of Director: Paul M. Bisaro	Management	For	For
1.3	Election of Director: Frank A. D’Amelio	Management	For	For
1.4	Election of Director: Michael B. McCallister	Management	For	For
2.	Advisory vote to approve our executive compensation (Say on Pay)	Management	For	For
3.	Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2019.	Management	For	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)		Tekla World Healthcare Fund
By (Signature and Title)*
			/s/ Daniel R. Omstead
			(Daniel R. Omstead, President)
Date	8/15/19

*Print the name and title of each signing officer under his or her signature.